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Summary  
Background: The small intestinal mucosa is the most difficult area of the hollow gastrointestinal 
(GI) tract to evaluate using endoscopic methods. Double-balloon enteroscopy (DBE) is one of the 
major endoscopic breakthroughs of this century. DBE for the first time enabled endoscopists to 
practically observe the entire small intestine, take biopsies and provide treatment 
Aim: We sought to evaluate various aspects on the technical and clinical utility of DBE. 
Methods: Prospective and retrospective cohort studies of patients undergoing DBE at our medical 
center. In addition, technical reviews on the utility, present and future utilizations of this 
endoscopic method. Results: 1) There was a significant improvement in DBE performance over 
time, including increased depth of insertion, decline in procedural time, “speed of insertion” and 
decreased used of fluoroscopy for both oral and anal DBE procedures. These parameters improved 
significantly after the initial 10 oral (15 anal) cases. 2) DBE was useful to reach a new diagnosis in 
33% and to confirm the diagnosis in two thirds of patients investigated for suspected small bowel 
malabsorption. 3) The frequency of lesions within reach of conventional upper and lower 
endoscopes definitely explaining the source of GI bleeding in patients referred for DBE was 
24.3%. 4) DBE with virtual chromoendoscopy is a helpful advanced endoscopic method for the 
evaluation and characterization of small bowel polyps in patients with familial adenomatous 
polyposis, in the characterization of angiodysplasias and the definition of the submucosal capillary 
network, but not for patients with Peutz-Jeghers polyps, pseudopolyps, celiac disease and erosive 
jejunitis. Conclusions:  1) DBE is not only time consuming but also is a challenging procedure 
which requires training and follows a learning curve. 2) DBE had fair diagnostic yield in a selected 
group of patients with malabsorption a repeat 3) Due to the significant amount of lesions 
potentially explaining the cause of obscure GI bleeding, repeat EGD and ileocolonoscopy should 
be performed in patients referred for DBE. 4) Virtual chromoendoscopy is a promising technique 
to potentially improve the characterization of small bowel diseases.  
 Key   words:   enteroscopy, double balloon enteroscopy, single balloon enteroscopy, small 
bowel, angiodysplasias, small bowel polyps, 
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I. Abbreviations 
CE    Capsule Endoscopy  
GI    Gastrointestinal    
DAE   Device-assisted enteroscopy  
DBE    Double balloon enteroscopy  
SBE    Single balloon enteroscopy  
NBI    Narrow band imaging 
FICE    Fujinon intelligent color enhancement  
OGIB   Obscure gastrointestinal bleeding  
EGD    Esophagogastroduodenoscopy  
EATL   Enteropathy-associated T-cell lymphoma  
CT   Computed tomography 
MRT   Magnetic resonance tomography  
WL   White light 
NSAID  Non steroidal anti-inflammatory drugs 
FAP   Familial adenomatous polyp syndrome 
PJS   Peutz-Jeghers syndrome 
NLH   Nodular lymphoid hyperplasia 
HGIN   High-grade intraepithelial dysplasia  
GIB   Gastrointestinal bleeding 
GAVE   Gastric antral vascular ectasias 
CO2   Carbon dioxide 
BAE   Balloon-assisted enteroscopy 
MAC   Monitored anesthesia care 
FIT   Fecal immunochemical tests 
SBFT   Small-bowel follow-through 
RCD   Refractory celiac disease  
CVID   Common variable immunodeficiency disorder 
NET   Neuroendocrine tumors 
EUS   Endoscopic ultrasound 
PET   Positron emission tomography  
APC   Argon-plasma-coagulation  
DPEJ   Direct percutaneous endoscopic jejunstomy  
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II. Chapter 1 
Introduction 
This thesis is about the technical and clinical aspects of double-balloon enteroscopy. The small 
intestinal mucosa is the most difficult area of the hollow gastrointestinal (GI) tract to evaluate 
using endoscopic methods. The introduction of capsule endoscopy (CE) into clinical practice a 
decade ago resulted a major breakthrough in endoscopic imaging of the small bowel, for the first 
time permitting a detailed view of the entire mucosal surface (1,2). Despite the multiple advantages 
of CE as a “non-invasive” endoscopic method, it still holds several limitations, which include 
inability to obtain tissue for diagnosis or to provide endoscopic intervention such as polyp removal, 
dilation of strictures or cauterization of angiodysplasias, or to actively evaluate a lesion, washing 
the fluids or stop at a specific place to observe the lesion (3). Thus, when tissue for diagnosis is 
essential or carrying out an endoscopic therapeutic intervention is mandatory, traditional 
endoscopic methods are essential. But until fairly recently the only endoscopic method available to 
investigate and treat luminal disorders of the small bowel was push enteroscopy (PE) (4). 
However, PE has major limitations regarding depth of inspection. Fortunately new methods of 
endoscopic investigation and therapy such as double- and single-balloon and spiral-enteroscopy 
were developed and introduced into clinical practice (3, 5-7). Double balloon enteroscopy (DBE) 
for the first time enabled endoscopists to practically observe the entire small intestine, take 
biopsies and provide treatment (5, 6) (Figure 1).  
 
 
Figure 1. Double balloon enteroscope 
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In 2007, Tsujikawa et al introduced single-balloon enteroscopy (SBE) (7). Because both methods 
use a balloon on the overtube as a major mechanism for performing the procedure, the term 
“balloon-assisted-enteroscopy (BAE) was coined by Mönkemüller et al (8). Spiral enteroscopy 
(SE) was introduced in 2008 by Ackerman et al, thereby increasing the endoscopic possibilities to 
investigate and treat disorders of the small bowel (9). However, BAE methods remain the most 
widely used (10). BAE is regarded as one of the major endoscopic breakthroughs of the new 
century. Its addition to capsule endoscopy revolutionized the approach to the diagnosis and 
treatment of small bowel disorders.  
In this thesis we will focus on the use of DBE. We first provide introduction into the technique of 
DBE. Then we evaluate the learning curve of DBE. In the next study we focus on determining the 
clinical applicability and utility of DBE for small bowel malabsorption states. In a large study we 
critically evaluate the role DBE in patients with obscure gastrointestinal bleeding and provide the 
Magdeburg algorithm for evaluation and treatment of obscure gastrointestinal bleeding. And 
finally, we explore the possibilities of advanced small bowel imaging using deep enteroscopy 
techniques. First we studied for the first time the utility of virtual chromoendoscopy for the 
diagnosis and characterization of various small bowel disorders and then we provide a state-of-the-
art approach to small bowel imaging, focusing on current methods and future trends.  
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III. Chapter 2 
OUTLINE OF THE THESIS 
Our medical center was a pioneer institution utilizing double-balloon enteroscopy. Thus, we had 
the opportunity to investigate early on the technical aspects and clinical utility of double balloon 
enteroscopy. As with every new technique, many questions were raised after the first experiences 
with double-balloon enteroscopy. In this thesis, some of these clinical and technical issues will be 
addressed. For this thesis our steadily growing, prospectively collected, institutional review board-
approved database of balloon-enteroscopy initiated in 2004, was used.  
 
Chapter three provides a brief introduction and overview of double-balloon enteroscopy. It 
explains the technique of DBE. It also explains how choose the route of inspection. Furthermore, 
the indications and contraindications as well as complications are presented.  
 
In chapter four we investigate the learning curve of DBE (1). DBE is a time consuming technique, 
which requires expertise in an effort to evaluate as much as possible length of the small bowel. 
There is scant data on the number of cases needed to acquire the skills necessary to perform DBE. 
Knowledge of this technical data may be helpful for endoscopists planning to perform DBE, to 
plan the caseload in individual endoscopy units and for establishing baselines for DBE skill 
certification.  
 
In chapter five we evalute the diagnostic value of DBE in patients with malabsorption of unclear 
origin (2). Malabsorption can be due to a wide range of processes including luminal, mucosal or 
submucosal etiologies. In most patients with malabsorption the diagnosis can be reached using 
standard methods but occasionally a specific diagnosis which includes direct visualization of the 
mucosa and tissue samples would be necessary to reach a diagnosis. In addtion, there are 
malabsorptive diseases that follow a patchy small bowel distirbution, thus mandating a deep 
enteroscopic evaluatuon. In this study, we investigate for the first time whether DBE detects 
mucosal lesions in malabsorption patients in segments of the small bowel that are usually not 
accessible to standard endoscopy.  
 
In chapter six we critically evaluate the role of DBE in patients with obscure gastrointestinal 
bleeding (OGIB) (3). The most common indication for performing double balloon enteroscopy 
(DBE) is OGIB. OGIB is currently defined as bleeding from the GI tract that persists or recurs 
without an obvious etiology after a negative initial EGD and colonoscopy, and can be categorized 
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into obscure overt and obscure occult bleeding based on the presence or absence of clinically 
evident bleeding. Because most OGIB originate in the small bowel, distal to the papilla of Vater 
and proximal to the ileocecal valve, OGIB is also rightly called mid-GI or mid-gut bleeding. Mid-
gut bleeding is currently evaluated using either capsule endoscopy (CE) and/or balloon-
enteroscopy. However, bleeding sources within reach of conventional upper and lower endoscopes 
can be missed because of inadequate endoscopic investigation, small size, atypical location and 
non-active bleeding. One of the most frustrating experiences for a double balloon or capsule 
endoscopist is to find lesions outside the small bowel, such as gastric or colonic angiodysplasias, 
given that usually upper and lower endoscopies have been performed prior to the DBE procedure. 
In addition, missing these lesions may result in prolonged diagnostic evaluation, patient 
inconvenience and increased costs. The magnitude of the problem of finding abnormalities outside 
the small bowel on DBE is not well known. Therefore, in this study we aimed to determine the 
incidence of lesions outside the small bowel potentially responsible for GI bleed in patients 
undergoing DBE for the indication of OGIB. By doing so we also aimed at creating a useful and 
modern algorithm for the evaluation of patients with OGIB. 
 
In chapter seven we examine the role of advanced imaging methods such as virtual 
chromoendoscopy (Fujinon enhanced color ernhancement, FICE) to characterize various small 
bowel disorders (4). The direct observation of the small bowel mucosa reached with DBE could be 
improved using techniques, which enhance the villous details of the gastrointestinal (GI) mucosa 
using “virtual chromoendoscopy” or “dye-less” techniques. The current dye-less chromoendoscopy 
techniques include optical chromoendoscopy such as narrow band imaging (NBI; Olympus, 
Tokyo, Japan) and virtual chromoendoscopy including i-scan (Pentax, Tokyo, Japan) and Fujinon 
intelligent color enhancement (FICE; Fujifilm, Tokyo, Japan). While NBI is based on optical filters 
within the light source of the endoscope which narrow the bandwidth of spectral transmittance, 
thereby enhancing the visualization of blood vessels, i-scan and FICE use digital postprocessing 
for computed spectral estimation for better tissue contrast. Both methods are based on narrowing of 
the bandwidth of the conventional endoscopic image. Because this computer is located within the 
processor, FICE is not dependent on the presence of optical filters inside of the videoendoscope. 
Our study is the first to systematically evaluate advanced imaging methods for small bowel 
pathologies.  
 
In chapter eight we provide a state-of-the-art review of advanced imaging methods for the small 
bowel (5). Standard white light endoscopes permit gross examination of the small bowel mucosa 
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permitting the recognition of minor and major defects such as erosions, ulcers, lymphangiectasias 
or abnormal duodenal folds. The water immersion technique increases our ability to inspect the 
small bowel villi by magnifying the view as well as providing a soluble medium where the villi 
and other superficial structures appear bigger and “move” inside the water. This technique can be 
very helpful when investigating conditions associated with villous atrophy such as celiac disease 
and other malabsorption syndromes. Magnification or zoom endoscopy further increases our ability 
to analyze the mucosal detail. Applying dyes and using magnification endoscopy can elucidate 
further architectural details of the mucosa. New dye-less or virtual chromoendoscopy techniques 
such as narrow band imaging (NBI), i-scan and Fujinon intelligent color enhancement (FICE) have 
further enhanced our optical capabilities for the evaluation of enteric mucosal and submucosal 
lesions. When using confocal laser endoscopy the targeted structure is magnified in such a way that 
a virtual histology image (“in vivo histology”) is achieved. We believe that in the near future 
confocal endomicroscopy may further help characterize and diagnose diseases affecting the small 
bowel such as celiac disease, Crohn’s disease, infections, vasculitis, mesenteric ischemia and 
angiodysplasias, among others.  
 
In chapter nine we evaluate the current and future trends in small bowel endoscopy (6). Here we 
summarize the latest advances in deep enteroscopy as presented in last year’s Digestive Diseases 
Week, which is the premier worldwide meeting in gastroenterology. In doing this review we want 
to demonstrate that deep enteroscopy has now become an established area of gastrointestinal 
endoscopy and that there is still a lot to learn about the small bowel. 
 
In chapter ten results of the thesis are summarized and discussed. 
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IV. Chapter 3 
Overview of double-balloon enteroscopy 
Technical aspects of DBE: 
Currently there are two major types of double balloon enteroscopes available for investigation of 
the small bowel (1-3). The working length of both EN-450P5 and EN-450T5 is 200 cm. The 
external diameter of the therapeutic DBE is 9.4 mm, whereas the diagnostic DBE has a diameter of 
8.5 mm. The diameter of the working channel of the therapeutic DBE is 2,8 mm whereas the 
diagnostic one is 2,2 mm wide. Knowledge of these details is important in order to choose the 
appropriate accessory materials such as biopsy forceps, snares and needles. Both channels allow 
for the passage of the standard biopsy forceps, snare, injection needle standard biliary catheter and 
the thin argon plasma catheter. The working channel of the “therapeutic” (“T-scope”) allows for 
introduction of snares, baskets, needles and any other therapeutic accessories. The EN-450T5 is 
used with a 145-cm overtube that has an external diameter of 13.2 mm and an internal diameter of 
11 mm. The diagnostic scope is used with a 105-cm overtube that has an external diameter of 13.2 
mm and an internal diameter of 11 mm.  
 
Technique: 
The use of the DBE in the pig- and the Erlangen training model increased our understanding of the 
mechanics and handling of the DBE (4). The major advantage of the DBE system is the presence 
of the balloons on both the overtube and endoscope, which help anker the scope and/or the 
overtube in difficult positions, providing further stability during the procedure (5, 6). By 
stabilization of the intestine through gripping of the intestinal wall with a balloon attached to the 
distal end of a flexible overtube it is possible to advance the enteroscope deeper while the overtube 
prevents further bending or looping of the intestine. Furthermore, the balloon attached to the 
endoscopic tip anchors the endoscope during the advancement of the overtube, thus preventing the 
intestine to slide back while the overtube is advanced towards the enteroscope (1-3, 5, 6). The 
endoscope moves forward using two balloons in sequence while folding and shortening the long 
intestine onto the overtube and making a concentric circle with its shaft.  
DBE is a complex examination and should thus only be carried out by experienced endoscopists 
who are well versed with the various pathologies of the small bowel. Skilled interventional 
endoscopists will also have the advantage of being able to utilize the enteroscope for biliary 
procedures, investigate the excluded stomach in patients with gastric bypass operations or to 
perform colonoscopies in patients with previously failed colonoscopy (7-11). Before attempting 
this procedure a through review of the basic principles of DBE is mandatory. Some experts 
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advocate the participation in workshops using the Erlangen or animal models. However, as with 
most endoscopic procedures, there is no better substitute than one-on-one training with an 
experienced endoscopist.  
The standard approach to perform DBE requires two persons, operator and assistant. In the 
standard DBE method, an assistant constantly holds the overtube, while an operator handles the 
enteroscope, and both assistant and operator perform the two movements of the push-and-pull 
maneuver. Araki et al described a single endoscopist method where these two movements are 
performed only using the right hand of one operator, catching the proximal end of the overtube 
with the thumb and the forefinger, and gripping the endoscope with the little and the third fingers 
and the posterior part of the palm (12). The right hand of the operator is also used to insert the 
endoscope through the overtube. The operator's left hand is used to pull back the endoscope and 
hold the endoscope handle. It appears that this method is equivalent to the “two-endoscopists” 
approach. However, we believe that the single-operator DBE method should be used in situations 
were general anesthesia is used because when conscious sedation is utilized, generally there is 
patient movement during the procedure and the additional physicians in the room assists not only 
to assist for the procedure, but aid in patient monitoring.  
 
Technical aspects of SBE  
The main difference when using SBE is the absence of a balloon on the tip of the enteroscope (13). 
The method also uses an overtube with a balloon on its tip. The push-and-pull maneuvers used to 
perform SBE are in essence the same as for DBE. In addition, most experts also advocate 
performing SBE with two operators. Recently DBE and SBE were compared in three prospective 
randomized studies (13-15). In the first study the rate of complete enteroscopy with DBE was three 
times higher than with SBE (14). DBE was also associated with a higher diagnostic yield. The 
second study was terminated because the total enteroscopy rate was 0% in the SBE group versus 
57% in the DBE group (15). There was no difference in the diagnostic rate and the therapeutic 
outcome between the SBE and DBE group. The third study showed no difference in total 
enteroscopy between SBE and DBE (13). Thus, the final verdict on which method reaches deeper 
is not out yet.  
 
Determination of the primary route of insertion (oral or antegrade versus anal or retrograde) 
The choice of either the oral or the anal route depends on the suspected location of the lesions 
within the small bowel based on the clinical manifestations, results of laboratory, radiological and 
CE examinations (1-3, 16, 17). For obscure gastrointestinal bleeding (OGIB) CE is currently the 
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main instrument used to indicate the preferential endoscope insertion route for DBE. Two studies 
have evaluated the “CE-directed approach” (18, 19). Pennazio et al. used this approach in a group 
of 44 patients and found that a one-sided procedure (oral or anal) was sufficient to reach the lesion 
of interest in almost 90% of the DBE examinations (18). Gay et al. reported on similar high yields 
(19). In cases of obscure GI bleeding the stool color can also help to direct the DBE route: the oral 
route in the case of melena and the anal route in the case of hematochezia. However, this approach 
has not been validated. In general, total enteroscopy by DBE is not required in the majority of the 
patients with OGIB, as the potential bleeding source can be generally identified without entire 
small bowel visualization. Nonetheless, about one third of patients will require two separate DBEs 
to make diagnosis.  
In most other situations the route of investigation depends on previous clinical and radiologic 
findings. For example, in patients with suspected Crohn’s disease using the retrograde approach 
makes more sense, as the terminal ileum is a major site of involvement in this disease. Patients 
with Peutz-Jeghers syndrome are usually evaluated using the antegrade approach first followed by 
the retrograde approach. 
 
Indications 
The most common indications for DBE are OGIB and evaluation of suspected Crohn’s disease (1-
3, 5, 6, 20, 21). Table 1 compiles the current indications for deep enteroscopy.  
 
Table 1. Indications and potential therapeutic interventions using the double balloon enteroscope 
Small bowel bleeding: 
Hemostasis 
  Argon plasma coagulation 
  Injection of Epinephrine 
  Injection of Hisytoacryl 
  Placement of clips 
Crohn’s disease 
 Stricture dilation 
Celiac disease (surveillance) 
Polyposis syndromes (surveillance) 
Polypectomy  
Endoscopic mucosal resection 
NSAID enteropathy 
Balloon dilation of strictures  
Tumors (adenocarcinoma, search for neuroendocrine tumors) 
Submucosal injection with India ink 
Small bowel and colonic stent placement 
Removal of foreign body 
PEG in altered bowel anatomy (gastric bypass, roux-Y) 
Biliary interventions: ERCP  
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Complications of DBE: 
Besides post-polypectomy bleeding and perforation, several unique complications related to DBE 
have been reported such as pancreatitis, intestinal necrosis from an epinephrine injection, 
intramural hematoma and paralytic ileus (22-24). Two large studies have reported on the 
complications associated DBE (23, 24). A large multicenter, international complication survey was 
presented by Mensink et al (23). A total of 10 centers across four continents participated in the 
study and reported on a total of 40 complications in 2362 DBE procedures, 13 in 1728 diagnostic 
DBE (0.8 %) and 27 during 634 therapeutic procedures (4.3 %). The complications were rated 
minor in 21 (0.9 %), moderate in 6 (0.3 %) and severe in 13 procedures (0.6 %). No fatal 
complications were reported. Seven cases of pancreatitis were reported, six after diagnostic (0.3 %) 
and one after therapeutic (0.2 %) DBE (40). Therefore pancreatitis should always be considered in 
patients with persistent abdominal complaints after DBE. In another study Moeschler et al 
contacted all endoscopic units using DBE in Germany and collected data during a 3-year period 
(24). 64 of 85 endoscopic centers responded to the questionnaire. Of a total 3894 reported DBE-
examinations (2685 using the oral route, 1209 using the anal route), including 1086 therapeutic 
interventions (857 APC-therapy, 177 polypectomies, 26 dilatations and 26 other) a total of 48 
complications were reported (1,2%). The most common complications were acute pancreatitis in 9 
patients (0,34%) with 1 lethality, perforation in 8 cases (6 post-polypectomy), major bleeding in 6 
patients (4 in the context of polypectomy and 2 after biopsy) (24). All patients received endoscopic 
treatment and recovered from this complication.  
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Abstract: 
DBE is a time consuming procedure. Although prospective research on the learning curve for this 
procedure are lacking, there is data from prospective cohorts that have evaluated the learning curve 
of DBE. It is evident that a significant amount of time and a minimum of 10-15 procedures are 
required to acquire the skills necessary to perform DBE. Knowledge of this technical data may be 
helpful for endoscopists planning to perform DBE, to plan the case load in individual endoscopy 
units and for establishing baselines for DBE skill certification.  
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Introduction: 
The double balloon enteroscope (DBE) has been employed since 2001 for evaluation of small 
disorders (1-5). There is still considerable clinical and research interest in evaluating the technical 
issues regarding DBE (6-10). DBE is a time consuming procedure. Although prospective research 
on the learning curve for this procedure are lacking, there is data from prospectively cohorts that 
have evaluated the learning curve of DBE. At the time of submission of this manuscript there were 
two abstracts and one article published on the learning curve of DBE (11,12). We will discuss the 
available information in this article. 
Technical aspects: 
Instruments and Materials: 
Currently there are two types of double balloon enteroscopes available for investigation of the 
small bowel. The working length of both EN-450P5 and EN-450T5 is 200 cm. The external 
diameter of the therapeutic DBE is 9.4 mm, whereas the diagnostic DBE has a diameter of 8.5 mm. 
The diameter of the working channel of the therapeutic DBE is 2,8 mm whereas the diagnostic one 
is 2,2 mm wide. Both channels allow for the passage of the standard biopsy forceps, snare, 
injection needle standard biliary catheter and the thin argon plasma catheter (APC catheter 20132-
212, Erbe, Tübingen, Germany). EN-450T5 is used with a 145-cm overtube that has an external 
diameter of 13.2 mm and an internal diameter of 11 mm. EC-450BI5 is used with a 105-cm 
overtube that has an external diameter of 13.2 mm and an internal diameter of 11 mm.  
Most initial experience with DBE was obtained with the diagnostic DBE. Many small bowel units, 
including ours, have currently both types of scopes available. Based on our experience and that of 
others, it appears that a faster and deeper small insertion is reached when using the therapeutic 
enteroscope, with exception of patients with previous abdominal surgery. As far as we know there 
are no comparisons published to date regarding technical handling issues between both scopes. 
Data evaluating the learning curves of DBE were mainly based on the diagnostic DBE. 
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Outcomes: 
We evaluated the learning curve of DBE in 140 patients undergoing 168 DBE by a single 
endoscopist during a 2-year period in a prospective cohort study (10). The following performance 
parameters were documented prospectively: depth of insertion, duration of the procedure, 
fluoroscopy use, endoscopic findings and therapeutic interventions. All procedures were performed 
using the diagnostic DBE. The performance parameters from the endoscopist’s initial 10, 15 and 
20 cases were compared to the subsequent examinations. The procedure duration was studied in 
relation to procedure date. In addition, the “speed of insertion” was also investigated (cm per 
minute).  
A total of 126 oral DBE and 42 anal DBE were performed. The mean (±SD) duration for both oral 
and rectal DBE were: 92.3 ± 38.6 minutes for the first 10 cases, 84.1 ± 35.5 minutes for the first 20 
cases (P < .005), and 64.1 ± 31.2 for the subsequent cases. Both rectal and oral DBE were 
performed significantly faster over time. The mean depth of insertion increased and the mean 
fluoroscopy exposure declined significantly over time. For oral DBE the mean insertion was 
150.4±15 cm for the first 10 cases, 170.4 ±25.2 cm for the first 15 cases and 245±22.4 for the 
subsequent cases (Figure). The mean ileal insertion for anal DBE was 30.5±15.8 for the first 15 
cases and 95,5±22.3 for the subsequent cases (p < 0,022). Deep ileal intubation via the anal route 
failed in 7 (17%) cases (40% of the initial 10 cases, versus 6% of the subsequent cases). There was 
a significant negative correlation between the procedure duration and the number of days from the 
endoscopist’s first procedure for both oral and anal procedures (p < 0,001). The depth of insertion 
and the “speed of insertion” correlated positively between the initial days of the procedure and 
subsequent days. 
Diagnostic or therapeutic interventions were performed in 86% of cases; DBE led to a diagnosis or 
therapeutic intervention in 111 (79%) patients. Only 8% of patients had prior capsule endoscopy. A 
total of three complications occurred (none severe): bleeding after polypectomy (n=1), ileus (n=1) 
and respiratory depression (n=1).  
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Figure 1. Over the time, the mean duration of DBE decreased while the reached distance in the 
small bowel increased. Expressed together in the term of insertion depth per time 
([cm/min](speed)), the examination improved significantly (r=0,226; p=0.037). 
 - 22 - 
Discussion: 
We have demonstrated that there was a significant improvement in DBE performance over time, 
including increased depth of insertion, decline in procedural time, “speed of insertion” and 
decreased used of fluoroscopy for both oral and anal DBE procedures. These parameters improved 
significantly after the initial 10 oral (15 anal) cases. In a multicenter study involving six U.S. 
tertiary centers with a total of 188 subjects undergoing 237 procedures, Mehdizadeh et al 
investigated the technical details the learning curve associated with DBE (11). The performance 
parameters from each center's initial 10 cases were compared to the subsequent examinations. The 
main outcome measurements were exam duration, depth of insertion, and findings on DBE 
examination. DBE was introduced by mouth in 149 (63%) cases, by rectum in 77 (33%) cases. The 
mean (±SD) duration was 109.1 ± 44.6 minutes for the first 10 cases and 92.4 ± 37.6 minutes for 
subsequent cases (P = .005) but did not change for rectal DBE procedures. There was no change in 
mean depth of insertion, but the mean fluoroscopy time declined significantly (P = .025). 
Diagnostic or therapeutic maneuvers were performed in 64% of cases; DBE led to a diagnosis in 
81 (43%) patients. One perforation occurred (0.4%). Per-rectal cases failed to reach the small 
bowel in 24 (31%) cases (11). The authors concluded that there was a significant decline in overall 
procedural time and fluoroscopy time after the initial 10 DBE cases. There was no improvement in 
performance parameters when DBE was performed via the rectal approach despite increased, but 
limited, operator experience (11). Although more data of additional centers are needed, we believe 
that knowledge of this technical data may be helpful for endoscopists planning to perform DBE, to 
plan the caseload in individual endoscopy units and for establishing baselines for DBE skill 
certification. Future studies using the therapeutic DBE and comparing the learning curve using 
both types of endoscopy may improve our knowledge on the learning curve of DBE. Nonetheless, 
it appears that a significant amount of time and a minimum of 10-15 procedures are required to 
acquire the skills necessary to perform DBE.  
 - 23 - 
References: 
1. Yamamoto H, Kita H, Sunada K et al: Clinical outcomes of double-balloon endoscopy for 
diagnosis and treatment of small intestinal diseases. Clin Gastroenterol Hepatol 2:1010–
1016, 2004. 
2. May A, Nachbar L, Wardak A et al: Double-balloon enteroscopy: preliminary experience in 
patients with obscure gastro-intestinal bleeding or chronic abdominal pain. Endoscopy 
35:985–991, 2003 
3. Ell C, May A, Nachbar L, Cellier C, et al: Push-and-pull enteroscopy in the small bowel 
using the double-balloon technique: results of a prospective European multicenter study. 
Endoscopy 37:613-616, 2005 
4. Heine GD, Hadithi M, Groenen MJ, Kuipers EJ, Jacobs MA, Mulder CJ. Double-balloon 
enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients 
with suspected small-bowel disease. Endoscopy 38:42-8, 2006 
5. Mönkemüller K, Weigt J, Treiber G, et al. Diagnostic and therapeutic impact of double-
balloon enteroscopy. Endoscopy 38:67-72, 2006 
6.  Di Caro S, May A, Heine DGN, et al: The European experience with double-balloon 
enteroscopy: indications, methodology, safety and clinical impact. Gastrointest Endosc 
62:545-550, 2006 
7. Sun B, Shen R, Cheng S et al. The role of double-balloon enteroscopy in diagnosis and 
management of incomplete  small-bowel obstruction. Endoscopy 39:511-5, 2007 
8. Zhong J, Ma T, Zhang C, Sun B, Chen S, Cao Y, Wu Y.A retrospective study of the 
application on double-balloon enteroscopy in 378 patients with suspected small-bowel 
diseases. Endoscopy 39:208-15, 2007 
9. Schäfer C, Rothfuss K, Kreichgauer HP et al. Efficacy of double-balloon enteroscopy in the 
evaluation and treatment of bleeding and non-bleeding small-bowel disease. Z 
Gastroenterol 2007;45:237-243. 
10. Mönkemüller K, Bellutti M, Malfertheiner P. Small bowel endoscopy. Endoscopy 
2007;39:978-85.  
11. Mehdizadeh S, Ross A, Gerson L, et al.What is the learning curve associated with double-
balloon enteroscopy? Technical  details and early experience in 6 U.S. tertiary care centers. 
Gastrointest Endosc. 2006;64:740-50. 
12. Mönkemüller KE, Bellutti M, Weigt J, Fry LC. Learning curve of double-balloon 
enteroscopy (DBE) [abstract]. Gastrointest Endosc 2007; 65: AB334 
 - 24 - 
 VI. Chapter 5.  
 
Utility of double-balloon enteroscopy  
for the evaluation of malabsorption 
 
Lucia C. Fry, Michael Bellutti, Helmut Neumann,  
Peter Malfertheiner, Klaus Mönkemüller 
 
Department of Gastroenterology, Hepatology and Infectious Diseases,  
Otto-von-Guericke University 
Magdeburg, Germany 
 
 
 
 
 
 
 
 
 
 
Published in Digestive Diseases 2008;26:134-9 (Impact Factor 1.5) 
 
 
 - 25 - 
 
Abstract:  
Introduction: Occasionally, patients with malabsorption represent a diagnostic challenge. Double-
balloon enteroscopy (DBE) allows deep and detailed examination of the small bowel.  
Aim: The aim of this study was to determine the diagnostic value of DBE in patients with 
malabsorption of unclear origin.  
Methods: DBE was performed in a total of 12 patients with clinical malabsorption. Biopsy 
specimens were taken from macroscopic lesions or from examined small bowel at three different 
levels of scope insertion depth. Tissue specimens were evaluated with standard hematoxylin and 
eosin, the modified Marsh classification and, when indicated, special stains for amyloidosis.  
Results: Fifteen DBE were successfully performed in 12 patients without complications. DBE 
with small bowel biopsies yielded a diagnosis in 8 patients (67%). A new diagnosis was reached in 
4 patients (33%). The new diagnoses included: Crohn’s disease, primary intestinal lymphagiectasia 
and jejunal amyloidosis. In none of these 4 patients did the duodenal biopsies yield a diagnosis. 
Also, DBE excluded enteropathy-associated T-cell lymphoma (EATL) and/or ulcerative jejunitis in 
symptomatic celiac disease patients.  
Conclusions: DBE had a diagnostic value of 42% in patients patients with malabsorption of 
unclear origin. In addition DBE was useful to rule out complications of long-standing celiac 
disease such as ulceratice jejunitis or EATL. DBE should be reserved for patients with unexplained 
malabsorption. DBE with jejunal and ileal biopsies appears to have a diagnostic value in patients 
with malabsorption, even when duodenal biopsies are histologically normal. 
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Introduction: 
Malabsorption can be due to a wide range of processes including luminal, mucosal or submucosal 
etiologies (1-3). Although a diagnosis can be reached in most patients with malabsorption, 
occasionally there are patients in whom a specific diagnosis cannot be reached using standard 
methods. Both, capsule endoscopy (CE) and double balloon endoscopy (DBE) have improved our 
ability to visualize the mucosa of the small bowel (4-7). CE was recently proposed as another 
potential diagnostic method for the evaluation of patients with malabsorption and celiac disease, 
refractory Whipple’s disease or graft-versus-host disease (8-10). However, using CE, lesions may 
only be depicted without the ability to obtain samples for histological examination. DBE allows for 
a detailed examination of the small bowel mucosa, obtain biopsies, and perform endoscopic 
interventions. In the present study, we investigated for the first time whether DBE detects mucosal 
lesions in malabsorption patients in segments of the small bowel that are usually not accessible to 
standard endoscopy. Therefore, the aim of this study was to determine the diagnostic value of DBE 
in patients with malabsorption of unclear origin.  
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Patients and Methods 
Twelve patients who were evaluated for malabsorption of small bowel origin at the Magdeburg 
University Medical Center (Otto von Guericke University, Magdeburg, Germany) were included. 
Exclusion criteria comprised pregnancy, clinical suspicion of bowel obstruction and inability to 
provide informed consent. The study was conducted and carried out in accordance to the Helsinki 
Declaration. The patients provided written informed consent to undergo endoscopy with the DBE 
after the endoscopist and attending physician had explained the procedure in detail to them. DBE 
was performed using Fujinon intestinoscopes (Fujinon EN-450 P5 and EN-450 T5, Fujinon 
Corporation, Saitama City, Japan). The technical details of DBE using this DBE have been 
presented in detail elsewhere (11). Depth of intestinoscope insertion into the small bowel was 
calculated based on the method described by May et al (12). Patients underwent small bowel 
cleansing on the day before the procedure using 4 Lt of a standard colon lavage solution 
(Kleanprep, Germany) and underwent the procedure after an overnight fast. All procedures were 
performed using conscious sedation with midazolam and disoprivan. An additional physician 
administered the sedatives. 
Before DBE, all patients had undergone a previous thorough diagnostic workup,  which included 
laboratory tests (hemoglobin, hematocrit, white blood count, differential, blood chemistries, liver 
function tests, iron studies, vitamin B12 and folate levels, albumin, kidney function tests), 
serological tests for celiac disease (anti-tissue transglutaminase, anti endomysial antibodies and 
anti gliadin antibodies), D-xylose test, stool fat estimation, as well as esophagogastroduodenoscopy 
(EGD) with duodenal biopsies and ileocolonoscopy with terminal ileum biopsies. All patients also 
underwent abdominal ultrasonography. In selected cases the following radiological imaging was 
performed: CT scan, MRT enterography. Two patients also underwent capsule endoscopy (CE) 
(Note: CE just recently became available in our institution). Malabsorption was defined on clinical 
and laboratory basis which included: lower extremity edema, alopecia, anemia, hypoalbuminemia, 
positive D-xylose test, prolonged prothrombin time, deficit of vitamins A, E, B12 and/or folic acid.  
During DBE the small bowel mucosa was assessed macroscopically and with the water immersion 
technique for a priori defined lesions which included: thinning or flatting of villi, scalloping, 
mosaicism, nodular appearance of the mucosal surface, presence of submucosal vessels, erosions, 
ulcers and tumors. An erosion was defined as a superficial defect of the mucosal surface less than 3 
mm. An aphtha was defined as a raised erosion surrounded by a red halo. Ulcers were defined as 
deep mucosal defects larger than 3 mm in diameter. The shapes of erosions and ulcers were: round, 
with heaped up borders, stellate, linear or punched out lesions. Endoscopic findings were 
considered jejunal if they were found in the proximal 3-4 meters. The proximal ileum was defined 
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as the small bowel located 4 meters distal to the pylorus. The terminal ileum was defined as the 
distal 50 cm of the small bowel. A succesful anal DBE was defined as intubation and inspection of 
at least 25 cm of terminal ileum. Biopsies were obtained using a forceps designed for use with the 
DBE (Fujinon Europe, Germany). 
Histological assesment: 
Small bowel biopsy specimens were fixed and preserved in 10% formalin for histopathological and 
immunohistochemical evaluation. In patients with suspicion of sprue, besides hematoxylin-eosin 
staining, anti-CD3 (DakoCytomation, Glostrup, Denmark) staining was performed for optimal 
assessment of the number of intraepithelial lymphocytes. Duodenal and small bowel biopsies were 
evaluated according to the modified Marsh criteria.  
In lymphangiectasia immunohistochemical evaluation included staining with anti-CD3, anti CD-31 
and anti-CD34 to distinguish between blood vessel and lymphatic capillars. Congo red-staining in 
polarized light, anti-amyloid P-component antibody and anti-lambda light chain-antibody were 
performed in one case, after histology revealed small amounts of amyloid deposits in the jejunum. 
 - 29 - 
Results  
The demographic, clinical and laboratory characteristics of the 12 patients with malabsorption who 
underwent DBE between February 2005 and July 2007 are summarized in Table 1. All patients 
were symptomatic and were suffering from chronic diarrhea and had clinical symptoms of 
malabsorption. Fifteen DBE were successfully performed in 12 patients, (2 patients anal and oral 
DBE, 10 oral DBE in 9 patients, and one anal DBE in one patient) without procedure-related 
complications. The median-depth of insertion of the intestinoscope was 225 cm (range 80-550 cm) 
beyond the pylorus and of 35 cm from ileo-cecal valve in the patient with anal approach (range 25-
80 cm). A total small bowel examination was possible in two patients: in one patient the cecum 
was reached twice from the oral route. In both cases examined using both the oral and anal route, 
approximately 80-90% of small bowel could be examined. The mean duration of the procedure 
was 48 min (range 35–70 min). Conscious sedation with midazolam low dose (2-3 mg) followed 
by disoprivan 280 to 470 mg was performed in 11 patients, the 4-year old patient received general 
anesthesia. 
Endoscopic findings included: flattening or disappearance of the villi, loss of folds and scalloping, 
easy visualization of submucosal vessels, aphtae, erosions, ulcers, pseudopolyps and 
lymphangiectasias. The endoscopic findings for each patient are depicted in Table 1. DBE with 
small bowel biopsies yielded a diagnosis in 8 patients (67%), this was new in 5 cases (42%) 
(lymphangiectasia, Crohn’s disease and amyloidosis) and confirmed in 3 patients (25%). The new 
diagnosis included: Crohn’s disease, primary intestinal lymphangiectasia and jejunal amyloidosis. 
The most striking findings were in patients with amyloidosis, refractory celiac disease, Crohn’s 
disease and primary lymphangiectasia (Figure 1). The patient with amyloidosis showed a localized, 
4 x 5 cm segment of edematous mucosa and plump ulcerated folds in the proximal jejunum (Figure 
2). These ulcers were irregular, deep, with heaped up borders and stellate-shaped, similar to 
Crohn’s disease, with the exception of a bluish-red discoloration. The patient with Crohn’s disease 
showed erosions and ulcers localized to the terminal ileum. The patient suffering from Cronkhite 
Canada-syndrome had giant fold gastritis and pseudopolyps of the colon. Interestingly, the 
duodenum and jejunum were charaterized by severe atrophic changes (Figure 3). In the jejunum 
the villi were not only atrophic but they were also elongated, with finger-like projections. In this 
patient, histology demonstrated classic findings of celiac disease (Marsh 3), but repeated celiac 
antibody testing remained negative. The clinical and histological features of this patient improved 
on steroids and magensium supplementation. In Case 3 a diagnosis of Crohn’s disease was finally 
reached after histopathological study of a full thickness ileal resection obtained laparoscopically. 
Histology revelaed non-caseating granulomas. This patient underwent two DBE with multiple 
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biospies, which were always interpreted as “non-specific” inflammation. This was in marked 
contrast with the severe endoscopic appearance of the ileum, which prompted us to inlcude a 
lymphoma in the differential diagnosis, which was the reason why she underwent a laparoscopy. 
Overall, histology confirmed endoscopic findings in 8 patients, but interestingly, in three patients 
with clear endoscopic features of mucosal atrophy the biopsy was negative and in one patient with 
intestinal lymphangiectasias demonstrated by CE and DBE, the histology was also negative. 
Histological findings of the duodenum were normal in four patients with isolated deep small bowel 
disease: Crohn’s disease of the ileum, primary lymphangiectasia and jejunal amylodosis. In the 
remaining patients the duodenal findings correlated with the jejunal pathology. 
 
  
Figure 1. Amyloidosis   Figure 2. Lymphangiectasia   Figure 3. Celiac disease 
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Table 1: Demographic, clinical and laboratory characteristics of the patients with malabsorption 
 
 
Alb=Albumin: normal value 35-52 g/l; Ca: Calcium: normal value 2,15 – 2,55 mmol/L; MCV: mean corpuscular volume  80-95 fl; 
Hb: haemoglobin 7,4-10 mmol/l; N: normal; CD: celiac disease; m=male; f=female 
N° Age Sex Indication 
Endoscopic 
findings 
Histology/ 
Diagnosis Alb Ca Hb MCV 
1 54 f 
Alopecia, dysgeusia, 
weight loss, crural edema, 
hypoalbuminemia, deficit 
of vit. B12 
complete villous 
atrophy 
Increased 
intraepithelial 
lymphocytes, Marsh 
type IIIc/ 
Cronkhite Canada 
Syndrome 
27,1 2,00 7,2 97 
2 57 m 
weight loss, anemia, 
abdominal pain, recurrent 
vomiting 
Edematous and 
ulcerated mucosa, 
ulcerative jejunitis 
mucosal and 
submucosal AL-
amyloid,deposits/ 
Amyloidosis 
33,5 N 7,4 N 
3 78 f 
Abdominal pain, intestinal 
obstruction, diarrhea, 
hypoalbuminemia, anemia 
Ulcerative ileitis, 
pseudopolyps, 
lymphangiectasia, 
erosions, aphthae 
Chronic inflammation, 
fibrosis, non-caseating 
granulomas 
(laparoscopy)/ 
Crohn’s disease  
32 2,14 6,7 N 
4 37 m Perianal fistulas, diarrhea, hypoalbuminemia,  villous atrophy 
Histology: normal 
Final diagnosis: 
Hyper-IgE-syndrome 
24,7 2,07 5,7 96 
5 4 m diarrhea, hypoalbuminemia 
Lymphangiectasias, 
exsuding of white 
fluid after biopsy, 
diffuse edema of folds, 
plump villi, 
pseudopolyps, 
Lymphanagiectasias/ 
Primary 
lymphangiectasias 
25,5 N N 73 
6 65 f Diarrhea, hypoalbuminemia, anemia 
Mucosal edema of 
distal jejunum and 
mild scalloping of 
folds, 
lymphangiectasia 
Normal 
Final diagnosis: 
unknown  
28 N 5,7 90 
7 72 m Refractory celiac disease,  hypoalbuminemia 
Villous atrophy, 
scalloping folds, 
lymphangiectasia 
subtotal atrophy, 
increased 
intraepithelial T-
lymphocytes (>40/100 
epithelial cells)/CD 
32 1,5 N 98 
8 42 f 
Hypocalcemia, abdominal 
pain, diarrhea, intolerance 
to milk products 
Villous atrophy, 
scalloping folds, 
edematous mucosa, 
micronodularity 
Atrophy of folds, 
crypts hyperplastic, 
increased 
intraepithelial 
lymphocytes, Marsh 
type IIIc/CD 
35,8 1,59 N 100 
9 32 f Refratory celiac disease, hypoalbuminemia 
plump and diminished 
folds, scalloping of 
folds, 
lymphangiectasia, 
exuding of white fluid 
after biopsy 
Subtotal/ 
total atrophy, 
increased 
intraepithelial T-
lymphocytes, celiac 
disease Marsh type 
I/CD 
28 2 N N 
10 23 f Hypoalbuminemia, recurrent crural edema 
Lymphangiectasias, 
diffuse edema of folds, 
plump villi 
Primary intestinal 
lymphanigiectasia 20,9 1,84 N N 
11 59 m 
Chronic diarrhea, chronic 
hepatitis B, lower 
abdominal pain, anemia 
mucosal atrophy, 
plump folds Normal 34,9 2,07 6,2 N 
12 65 m Diarrhea, hypoalbumiemia Villous atrophy, plump folds 
Unspecific 
inflammation, 
flattened villi 
28,3 N N N 
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Discussion: 
This is the first study investigating the utility of DBE in patients with malabsorption of small 
bowel origin. We found that DBE had a high diagnostic yield in a selected group of patients with 
malabsorption in whom previous extensive investigations had been negative. DBE was useful to 
reach a new diagnosis in 33% and to confirm the diagnosis in two thirds of patients investigated. 
This high yield does not mean that DBE should be used as a primary tool in patients with 
malabsorption. Our study rather demonstrates that malabsorptive diseases with primary small 
bowel mucosal involvement could be adequately evaluated with DBE. In our study, DBE allowed 
for a detailed characterization of the morphology of the small bowel mucosa, permitting a proper 
localization and extent of small bowel involvement. In addition, small bowel biopsies were 
obtained for histological analysis. This was most helpful in the patients with lymphangiectasias and 
jejunal amyloidosis. Nonetheless, despite the ability to analyze the mucosa with histological 
methods a diagnosis could not be reached in up to one third of patients. Three patients had clear 
endoscopic abnormalities but the histology was entirely normal. In addition, in one patient with 
high suspicion of Crohn’s disease based on her clinical and endoscopic findings, the histology was 
repeatedly negative, and it was not until a full-thickness small bowel specimen was obtained via 
laparoscopy that a final diagnosis was reached.  
Our case series confirms that reaching a diagnosis in patients with malabsorption of small bowel 
origin can be a challenge, and that DBE might be a useful method in this setting. Nevertheless, it is 
clear that the investigation of malabsorption should follow standardized algorithms (13). DBE 
appears to be useful when there is a high suspicion that the mucosal phase of absorption is affected. 
Although our series is small, it provides information on the potential place of DBE in the 
diagnostic algorithm of these patients. DBE appears to have its greater value in patients in whom 
standard upper and lower endoscopy have been negative, as well as in patients in whom it is 
important to rule out complications of long-standing or severe celiac disease. This latter issue was 
elegantly addressed by Mulder’s group in Amsterdam (14). Hadithi et al prospectively assessed the 
value of DBE in patients with refractory celiac disease. Twenty-four procedures were successfully 
performed in 21 patients. Enteropathy-associated T-cell lymphoma (EATL) was found in five 
patients (24%) as circumferential, discrete, or confluent ulcerations. Furthermore, DBE could 
exclude the presence of EATL in four patients that was suggested by abdominal computerized 
tomography. This study demonstrated that complications of refractory celiac disease like ulcerative 
jejunitis or EATL could efficiently be detected or excluded by DBE (14).  
Although we are presenting the first study using DBE to investigate malabsorption, there is one 
previous study evaluating the use of push enteroscopy in patients with chronic diarrhea and 
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biological signs of intestinal malabsorption but no evidence of celiac disease. In that study 
Cuillerier et al. found that push enteroscopy had a diagnostic value of only 12% (15). In that study 
in none of the patients with normal duodenal biopsies did jejunal biopsies add any new diagnosis 
(15). We believe that our diagnostic yield was higher because DBE allowed for deeper inspection 
of the small bowel. The study of Hadithi et al. in patients with long-standing celiac disease and 
EATL further confirms the utility of DBE for investigating more extensive parts of the small bowel 
(14). The superiority of DBE over push enteroscopy in terms of depth of visualization of small 
bowel has also clearly demonstrated by Matsumoto et al. (7). 
Although small our study is the largest series of patients with malabsorption being investigated by 
DBE. Potential limitation of the study are: a) the relatively limited number of patients and b) the 
patient selection bias in a referral center like ours. However, our patients reflect the population 
seen at similar tertiary centers throughout the world. In addition, our patients were carefully 
evaluated before undergoing DBE, following accepted algorythms for the work-up of 
malabsorption.  
In summary, DBE had diagnostic value of 67% in patients patients with malabsorption of unclear 
origin. DBE with jejunal and/or ileal biopsies provided a new diagnosis in 33% of patients with 
malabsorption, even when duodenal biopsies were histologically normal. In addition DBE was 
useful to rule out complications of long-standing celiac disease such as ulceratice jejunitis or 
EATL. DBE should not be used in the initial stages of the work-up of malabsorption, but rather be 
employed in patients in whom an extensive work-up has been conducted and mucosal disease is a 
likely cause of malabsorption. 
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Abstract 
Background and Aims: Double balloon enteroscopy (DBE) is a useful method for evaluation of 
obscure gastrointestinal bleeding (OGIB). The study aim was to determine the incidence of lesions 
within reach of conventional upper and lower endoscopes as the cause of OGIB in patients referred for 
DBE. 
Methods: All patients undergoing DBE for OGIB at a university hospital were studied. OGIB was 
defined according to AGA guidelines.  
Results: 143 DBEs were performed in 107 patients for obscure overt (n=85) and obscure occult 
(n=22) GIB. Lesions outside the SB as possible sources of GIB were found in 51 patients (47.6%) and 
a definite source of bleeding outside the small bowel (SB) was detected in 26 patients (23.4%). 
Lesions considered to explain a definite source of GIB were: gastric ulcer (n=3), duodenal ulcer (n=3), 
Cameron’s lesions (n=2), gastric antral vascular ectasias (n=4), radiation proctitis (n=1), radiation 
ileitis (n=2), colon angiodysplasias (n=3),and others (n=7).  
Conclusions: The frequency of non-small bowel lesions definitely explaining the source of GI 
bleeding in patients referred for DBE was 24.2%. Therefore, repeat EGD and ileocolonoscopy should 
be taken into consideration before DBE.  
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Introduction: 
The most common indication for performing double balloon enteroscopy (DBE) is obscure 
gastrointestinal bleeding (OGIB) (1-4). OGIB accounts for approximately 5% of all GI bleeds, and 
is currently defined as bleeding from the GI tract that persists or recurs without an obvious etiology 
after a negative initial EGD and colonoscopy, and can be categorized into obscure overt and 
obscure occult bleeding based on the presence or absence of clinically evident bleeding (5). 
Because most OGIB originate in the small bowel, distal to the papilla of Vater and proximal to the 
ileocecal valve, OGIB is also rightly called mid-GI or mid-gut bleeding (5,6). Midgut bleeding is 
currently evaluated using either capsule endoscopy (CE) and/or balloon-enteroscopy (2,4,7,8). 
However, bleeding sources within reach of conventional upper and lower endoscopes can be 
missed because of inadequate endoscopic investigation, small size, atypical location and non active 
bleeding. One of the most frustrating experiences for a double balloon or capsule endoscopist is to 
find lesions outside the small bowel, such as gastric or colonic angiodysplasias, given that usually 
upper and lower endoscopies have been performed prior to the DBE procedure. In addition, 
missing these lesions may result in prolonged diagnostic evaluation, patient inconvenience and 
increased costs. The magnitude of the problem of finding abnormalities outside the small bowel on 
DBE is not well known. 
The aim of this study was to determine the incidence of lesions outside the small bowel potentially 
responsible for GI bleed in patients undergoing DBE for the indication of OGIB.  
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Patients and Methods: 
Consecutive patients who were evaluated for OGIB between October 2004 and August 2008 at 
University of Magdeburg Medical Center (Universitätsklinikum Magdeburg, Otto von Guericke 
University, Magdeburg, Germany) were included and their data recorded in a prospectively 
collected database. The study was approved by the ethics committee of the University of 
Magdeburg and conducted out in accordance to the Helsinki Declaration.  
All patients provided written informed consent to undergo DBE, including endoscopic therapy. 
Data abstracted for analysis from the prospectively collected database included patient’s 
demographics, past medical history, laboratory values, indication for endoscopy, history of co-
morbid illnesses, social history, medications, reports of prior endoscopies, results of endoscopic 
biopsies (if any), and technical and endoscopic findings on DBE. OGIB was defined according to 
AGA guidelines (5). Thus, all patients underwent EGD and colonoscopy prior to DBE. These 
endoscopies were performed within one week of DBE. 
DBE was performed using Fujinon enteroscopes (Fujinon FN 450P 5/20, EN-450T5, Fuji, Fujinon 
Corp., Saitama, Japan). From October 2004 to February 2006 all DBE were performed using the 
diagnostic DBE (FN 450P) and from February 2006 onwards all DBE for OGIB were performed 
using the therapeutic DBE (EN-450T5). With the availability of both DBEs, it is the policy in our 
unit to perform all DBE that have potential therapeutic consequences with the EN-450T5 scope. 
The characteristics of the DBE have been presented in detail elsewhere (2,9). Depth of enteroscope 
insertion into the small bowel was calculated based on the method of May et al (10). The DBE was 
considered of limited technical success if <20 cm of small bowel were visualized. All patients 
underwent small bowel cleansing before the procedure using a standard colon lavage solution 
(Kleanprep®, Norgine, Marburg, Germany) and underwent the procedure after an overnight fast. 
All the DBE were performed in our endoscopy suite dedicated for fluoroscopic procedures. 
Fluoroscopy was performed using a Philips C-arm (Philips®, Best, Holland). All procedures were 
performed using conscious sedation with propofol (Lipuro®, Braun, Melsungen, Germany, which 
was administered by one physician.  
Any mucosal lesion not located in the small bowel, distal to the papilla of Vater and proximal to 
the ileocecal valve was considered “outside the small bowel” (i.e. outside the reach of a 
gastroscope and colonoscope). The terminal ileum was not included in this definition as a 100% 
ileal intubation is not always achievable. We used a clinical classification to categorize bleeding 
lesions (8). Nakamura classifies GI lesions based on the clinical action taken to treat them into 1) 
A1: immediate haemostatic measures required, and 2) A2: close observation required). If patients 
had more than one diagnosis the likely cause of bleeding was defined based on endoscopic and 
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clinical findings. For example if the patient with maelena was found to have varices with stigmata 
of bleeding and few small bowel erosions or portal jejunopathy, the varices were considered to be 
the cause of GIB. Similarly, if the patient had occult obscure GIB and during endoscopy colonic 
diverticuli were found, but the patient also had multiple angioectasias of the small bowel, the latter 
were considered the likely cause of bleeding. Furthermore, lesions were defined as “possible” or 
“definite” source of bleeding, based on clinical criteria. If the patient had overt GI bleeding 
(melena or hematochezia) none of the following lesions were considered as “definite” cause of 
acute GI bleed: erosive esophagitis grade A or B, small esophageal varices without stigmata of 
bleeding or red whale signs, non-specific duodenitis, minimal gastric antral vascular ectasias, 
single colonic angiodysplasias, hemorrhoids without stigmata of bleeding. If the patient presented 
with occult GI bleeding any lesion was categorized as “possible”, except colon diverticulosis, 
esophageal varices and hemorrhoids. 
 
Determination of the primary route of insertion (oral or antegrade versus anal or retrograde) 
The choice of either the oral or the anal route depended on the suspected location of the lesions 
within the small bowel based on the clinical manifestations (e.g. melena or hematochezia), results 
of laboratory, radiological and previous endoscopic examinations. In cases of obscure overt GIB 
the route of insertion was dictated by the color of the stool; in cases of melena the oral approach 
was preferred, whereas in the presence of hematochezia the anal approach was used first. If a 
patient had undergone CE, we used the results of this test to guide the insertion route. CE was not 
available at our institution until the latter part of 2006. A combined oral and anal approach was 
employed if now source of bleeding could be identified using the initial route, i.e. if one DBE route 
did not yield any diagnosis the opposite route was used for the second investigation. To confirm 
total enteroscopy India ink marking of the small bowel was performed. Total enteroscopy was also 
confirmed if the cecum or colon could be visualized when using the oral approach. Complications 
of DBE were defined according to standard criteria (11). Descriptive statistics were employed to 
describe the patient’s demographics and clinical characteristics, presenting means and ranges. 
 
Results: 
We performed 143 DBE procedures in 107 patients. The type of OGIB was obscure overt (n=85) 
and obscure occult (n=22). The characteristics of the study group are presented in Table 1. The 
route for DBE was oral (n=108), anal (n=35). The mean duration of the procedure was 75 minutes, 
(range 25-150). The mean radiation exposure was 185 dGy/cm2 (range 0-1462). The mean small 
bowel insertion was 300 (range 30–540 cm, excluding cases with limited technical success, see 
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below and table 2). The depth of insertion was deeper when performing per oral DBE (mean 224 
cm, range 30 to 540), as compared with anal DBE (mean 55 cm, range: 0 to 120 cm) (p < 0.01). In 
10 patients (9.3%) it was possible to evaluate the entire small bowel (in 7 patients using both oral 
and anal routes, and in 3 patients it was possible to intubate the cecum via the oral route). There 
were a total of 6 DBEs with limited technical success (5 anal, 1 oral) (Table 2). In 5 anal DBE it 
was either impossible to intubate the ileum or less 20 cm of ileum were visualized. In the oral DBE 
with limited technical success the efferent limb could only be intubated 40 cm distal to the 
anastomosis. Further advancement was impossible due to adhesions that resulted from previous 
surgery.  
A potential small bowel etiology of GI-bleeding was found in 69 patients (64.5%). Findings 
included angioectasias/angiodysplasias (n=34), erosive and NSAID-induced small bowel injury or 
jejunal ulcers (n=12), small bowel tumors (n=6), Dieulafoy’s lesion (n=3), portal-hypertensive 
jejunopathy (n=3), Crohn’s disease (n=3), jejunal varices (n=2) and others (n=6) (Table 3).  
Lesions within reach of conventional upper and lower endoscopes either as definite or possible 
sources of GI bleeding were found in a total of 51 patients (47.6%). Findings within reach of 
conventional upper and lower endoscopes included colonic diverticulosis (n=11), gastric or 
duodenal ulcers (n=6), colonic angiodysplasias (n=5), gastric antral vascular ectasias (n=5), 
Cameron’s lesions, (n=2), hemorrhoids (n=1), esophageal varices (n=1), gastritis (n=4), and others 
(n=16) (Table 4).  
A definite source of bleeding within reach of conventional upper and lower endoscopes was 
detected in 26 patients (24.3%). Lesions considered to explain a definite source of GI blood loss 
were: gastric ulcer (n=3), duodenal ulcer (n=3), Cameron’s lesions (n=2), gastric antral vascular 
ectasias (prominent) (n=4), radiation proctitis (friable and bleeding on minor touch) (n=1), 
radiation ileitis (n=2), duodenal angiodysplasias (active bleeding) (n=1), hemorrhoids with 
stigmata of recent bleed (n=1), colon angiodysplasias (multiple cecal angiodysplasias) (n=3), colon 
diverticulosis (in patients with hematochezia and in the absence of blood in the small bowel) (n=3), 
colonic Crohn’s disease (n=1), anastomotic ulcers (n=1) (friable mucosa, spontaneous bleeding) 
(Table 4). 
A possible source of bleeding within reach of conventional upper and lower endoscopes was found 
in 25 patients (23.4%) (Table 4). In 20 patients (18,7%) a definite bleeding source could neither be 
identified by DBE nor by EGD and colonoscopy. 
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Table 1. Demographic and clinical characteristics of the study group.  
Total  n = 107 patients  
Age (mean  ± SEM) 64  + 10.9 (range 19 - 88) 
Sex Female 40 (37.4%) 
   
DBE, total n = 143  
Oral DBE only n=87  
Anal DBE n=14  
Oral and anal DBE n=21  
Indications  Obscure overt GIB 85 
 Obscure occult GIB 22 
DBE, double-balloon enteroscopy; GIB=gastrointestinal bleeding;  
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Table 2.  
DBE of limited technical success: Clinical, technical, endoscopic aspects and final diagnosis 
Route Indication Endoscopic/technical 
aspects 
Finding Final diagnosis 
Oral hematochezia partial gastric resection 
and Billroth II anastomosis 
Active bleeding from 
anastomosis  
Anastomotic ulcers  
Anal hematochezia Oral DBE was normal Massive diverticulosis and 
fresh blood in the colon 
Colon diverticulosis 
Anal hematochezia Intubation up to 15 cm of 
ileum normal 
Hemorrhoids with active 
bleeding 
Hemorrhoids 
Anal hematochezia Failed ileum intubation Multiple cecal 
angiodysplasias 
Cecal angiodysplasias 
Anal Hemoccult + 
anemia 
Normal oral DBE (350 cm 
of small bowel visualized) 
Failure to intubate ileum No diagnosis  
Anal Hemoccult + 
anemia 
Oral DBE: multiple 
jejunum angiodysplasias 
Failed ileal intubation SB angiodysplasias 
DBE=double balloon enteroscopy;  
* Efferent limb could only be intubated 40 cm distal to the anastomosis. Further advancement was impossible due to 
adhesions that resulted from previous surgery. 
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Table 3. Small bowel diagnosis in the study cohort. 
 Total 
Angioectasias / angiodysplasias 34 
NSAID-induced small bowel injury 10 
Small bowel tumors*  6 
Dieulafoy’s lesion 3 
Portal hypertensive jejunopathy 3 
Crohn’s disease 3 
Undiagnosed ulcers 2 
Jejunal varices 2 
Polyps** 2 
Small bowel diverticulum   1 
Giant arteriovenous malformation 1 
Ischemic jejunitis 1 
Leucocytoclastic vasculitis (Henoch-Schönlein purpura) 1 
 A potential small bowel etiology of GI bleeding was found in 69 patients (64.5%). 
*Tumors included 3 adenocarcinomas, 2 neuroendocrine tumors and 1 metastasis from testicular cancer 
**Ulcerated lipoma, inflammatory polyp 
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Table 4. GI bleeding sources within the reach of conventional endoscopes 
 Possible Definite 
 Obscure 
occult  
Obscure 
overt  
Obscure 
occult 
Obscure 
overt 
Total 
Colon diverticulosis 5 3 0 3 11 
Colon angiodysplasias 1 1 1 2 5 
Haemorrhoids 0 0 0 1 1 
Portal hypertensive colonopathy 1 0 0 0 1 
Segmental colitis (colonic Crohn’s 
disease or ischemic colitis) 
1 0 0 2 3 
Radiation proctitis 0 0 0 1 1 
Radiation ileitis 0 0 2 0 2 
Unspecific ileitis 1 1 0 0 2 
Gastric or duodenal ulcers 0 0 2 4 6 
GAVE 1 0 3 1 5 
Cameron’s lesions 0 0 1 1 2 
Duodenitis 3 0 0 0 3 
Esophageal varices 0 1 0 0 1 
Erosive esophagitis  2 0 0 0 2 
Gastritis 4 0 0 0 4 
Duodenal angiodysplasias 0 0 1 0 1 
Anastomotic ulcer 0 0 0 1 1 
Total (% of study cohort, n=107) 19 
(17,8%) 
6 
(5,6%) 
10 
(9,3%) 
16 
(14,9%) 
51  
(47,6%) 
Total 25 (23,4%) 26 (24,2%) 51 (47,6%) 
 
GI=gastrointestinal; GAVE: gastric antral vascular ectasias 
Some lesions were not considered as neither definite nor possible cause of GIB (please refer to text, 
materials and methods). 
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Discussion: 
In this large study we found that in patients investigated for OGIB with DBE it is common to find 
lesions within reach of conventional upper and lower endoscopes that could explain the obscure GI 
blood loss either as a primary or associated cause. Lesions within reach of conventional upper and 
lower endoscopes were found in more than half the patients investigated and these were present in 
both the upper and lower GI tract. Although not all these lesions could explain the GI blood loss in 
patients with OGIB, such as colon diverticulosis, duodenitis and haemorrhoids, it is evident that 
many definite bleeding lesions were missed during EGD and colonoscopy performed before DBE. 
These lesions included peptic ulcers, colonic angiodysplasias, Cameron’s lesions and radiation 
proctitis. Lesions such as these can be considered a definite source of GI blood and were found in 
one 24.3% of patients undergoing DBE for suspected small bowel bleeding. Although similar data 
regarding the yield of push enteroscopy were published more than a decade ago, our study has the 
advantage of having investigated both proximal and distal lesions (12, 13). In the push enteroscopy 
studies only missed upper GI lesions were evaluated. Because push enteroscopy is performed only 
via the oral route there are no data available regarding missed lesions in the lower GI tract. 
Furthermore, data from previous push enteroscopy studies cannot just be extrapolated to DBE. It is 
now clear that the depth of insertion of push enteroscopy is less than that of double balloon 
enteroscopy. Thus, DBE permits a better appreciation of small bowel lesions than other invasive 
endoscopic methods and is thus considered the current gold standard to diagnose and treat a large 
variety of small bowel disorders. Therefore, we believe that our study has several potential relevant 
clinical implications. Firstly, performing an unnecessary DBE will result in patient inconvenience. 
DBE is an invasive procedure which can result in complications, which albeit low, are associated 
with significant morbidity. DBE complications are either directly related to the procedure (i.e. 
perforation and pancreatitis) or due to sedation (i.e. arrhythmias, hypotension, respiratory failure) 
(11, 14-16). Pancreatitis is a complication which appears to be uniquely associated with balloon 
enteroscopy (11, 14-16). Secondly, DBE is a demanding and time consuming procedure. Thus, 
performing an unnecessary investigation adds a strain on the utilization of endoscopic human and 
material resources. And lastly, in patients with OGIB DBE should be used judiciously and repeat 
EGD and ileocolonoscopy should be taken into consideration before performing DBE. In addition, 
performing a capsule endoscopy (CE) may also be helpful. If no lesions are found, CE may obviate 
the need for an invasive DBE, and if a lesion is detected it would point to the diseased segment to 
be investigated with the DBE. Therefore, CE and DBE should be viewed as tests complementing 
each other. Even though performing a CE or repeating EGD and ileocolonoscopy can add to the 
total costs of care, their use can lead to a specific diagnosis in a significant percentage of patients. 
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Repeating EGD and colonoscopy in patients with OGIB probably also applies to patients that are 
referred for CE. In a recent study, Elijah et al. also found that up to 38.8% of patients undergoing 
CE for OGIB had significant lesions of the upper GI tract such as GAVE, gastric ulcers and 
Cameron’s lesions (17).  
Per definition, the vast majority of OGIB should originate from the small bowel, distal to the 
papilla of Vater and proximal to the ileocecal valve, and thus are called mid-GI or mid-gut 
bleeding (6). However, the etiology of OGIB may vary depending on various factors including the 
quality of clinical and endoscopic investigation. As shown in our study, form one fourth to one half 
of the episodes OGIB may have originated within reach of conventional upper and lower 
endoscopes. In our cohort, however, not all the lesions within reach of conventional upper and 
lower endoscopes (e.g. colon diverticulosis) could be considered as the primary culprits of OGIB. 
Nevertheless, evident lesions such as GAVE, Cameron’s lesions and gastroduodenal ulcers can be 
certainly considered as a definite source of “obscure” overt or occult GI bleeding. In patients with 
more than one lesion it is difficult to exactly pinpoint the bleeding source. However, by using the 
Nakamura classification as well as clinical and endoscopic findings we believe that we were able 
to classify most lesions in the best possible way.  
There are various possible explanations of why lesions can be missed. Occasionally their size or 
location such as Dieulafoy’s ulcer or Cameron’s lesion precludes their proper visualization. 
Sometimes a sub-standard colon preparation may impede visualization of cecal angiodysplasias. 
Furthermore, failure to intubate the terminal ileum may hamper the discovery of ileal ulcers, 
radiation enteritis or blood emanating from the small bowel. However, we believe that in the 
current era of video- and high definition endoscopy, these obvious lesions should not be missed. 
We suspect that several of the “obvious” gastroduodenal ulcers, varices of portal gastropathy were 
either missed because of operator’s inexperience or the performance of a ”quick” and/or 
“superficial” EGD or colonoscopy. Too often we have seen endoscopists in endoscopy units 
around the world, including ours, perform a “quick” EGD, not even taking enough time for a 
proper retroflexion. One could argue that by using the oral approach an “EGD” is also performed 
during DBE. Thus, some endoscopist may feel secure that a DBE will follow when either the EGD 
or colonoscopy were negative. This is true, and in fact, a thorough DBE should always include an 
inspection of the upper GI tract. However, the time planning and use of resources is much larger 
when performing DBE. The AGA guidelines define obscure GI bleeding as bleeding from the GI 
tract that persists or recurs without any obvious etiology after EGD and colonoscopy (5). The AGA 
guidelines recommend to repeat EGD or colonoscopy if there is a suspicion of an overlooked 
lesion (5). However, based on our findings it appears that a routine second look upper and lower 
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endoscopy is indicated before proceeding with further investigations such as CE and/or DBE (see 
algorithm, Figure 1).  Although it is possible that any operator can miss lesions, a rule of thumb is 
to definitely repeat the EGD and/or colonoscopy if the endoscopist who performed the initial 
endoscopy either used suboptimal equipment, has less endoscopic experience, there was 
inadequate mucosal visualization due to poor colon preparation or there is no clear documentation 
of the landmarks seen.  
We want to acknowledge potential limitations of our study. First, the study was not designed 
prospectively. However, at our institution we have a prospectively collected database containing 
the clinical and laboratory information of all patients undergoing DBE. Second, we are a tertiary 
center, and the pathologies observed here may differ from other settings. Nonetheless, our 
diagnosis mirrored those of other studies using DBE (1-4). Third, our definition of “possible” and 
“definite” source of GIB would need confirmation by others. However, this definition is a potential 
advantage of our study, specially because it is based on commonly applied clinical criteria. In 
addition, most previous studies did not use any exacter definition for GIB, some even considered 
gastritis as a bleeding source (12-14, 17). 
In summary, we found that the frequency of within reach of conventional upper and lower 
endoscopes definitely explaining the source of GI bleeding in patients referred for DBE was 
24.3%. Therefore, a repeat EGD and ileocolonoscopy should be considered before DBE. And these 
examinations should be performed thoroughly. At times of limited endoscopic capacities DBE 
should be employed judiciously in order to reduce patient inconvenience and to better allocate 
endoscopist, nurses and material resources in the endoscopy unit. Further studies focusing on the 
clinical and laboratory factors that can predict the etiology of small bowel pathologies in the 
setting of OGIB are warranted. 
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Obscure GI-bleeding (GIB)
Obscure-occult Obscure-overt
angiogramSpecific management
Repeat routine
endoscopy*
**Risk stratification; 
symptomatic therapy
No further work-up repeat algorithm
No recurrence
BAE
Capsule
endoscopy (CE)
++
patient clinically unstable
recurrence
Intraoperative 
enteroscopy
*In your institution (even if EGD and colonoscopy have been performed previously; BAE = balloon assisted enteroscopy; 
** risk stratification: if high risk continue searching for source of anemia; 
***There is no solid scientific evidence on when to perform CE. Based on the published literature and clinical experience it is 
recommended to perform CE in patients with obscure occult GIB, followed by DBE if the CE was positive,  and to perform 
DBE if the type of obscure GIB is overt. However, currently, the use of CE will mostly depend on local possibilities. 
-
-
-
+
-
-
***
 
Figure 1. University of Magdeburg Algorithm for the investigation of obscure gastrointestinal bleeding 
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Abstract  
Fujinon intelligent color enhancement (FICE) system is a new, virtual chromoendoscopy technique 
that enhances mucosal visibility. The objective of this study was to assess the utility of double-
balloon enteroscopy (DBE) with FICE-technology (EPX-4400 processor, Japan) for the 
characterization of various small bowel diseases. Overall, a total of 574 endoscopic pictures were 
obtained and analyzed. FICE was found to be a helpful method for the evaluation of adenomatous 
small bowel polyps and angiodysplasias. Its use for the characterization of celiac and Crohn´s 
disease appears to be limited. Overall, FICE may become a useful method that aids in the 
characterization and provides new insights of small bowel pathologies. 
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Introduction:  
Standard dye-based chromoendoscopy techniques enhance the villous details of the gastrointestinal 
(GI) mucosa (1-3). Currently, two imaging techniques that enhance the mucosal surface without 
the use of dyes exist (“virtual chromoendoscopy”) (4-7). Both methods are based on narrowing of 
the bandwidth of the conventional endoscopic image. Whereas with Olympus technology narrow 
band imaging (NBI) is based on the presence optical filters within the light source of the endoscope 
which constrain the bandwidth of spectral transmittance, with FICE (Fujinon intelligent color 
enhancement) the bandwidth of the conventional endoscopic image is narrowed down 
arithmetically using a computerized spectral estimation technology (4-7). Because this computer is 
located within the processor, FICE is not dependent on the presence of optical filters inside of the 
videoendoscope (4, 7). 
Whereas different studies have focused on the use of virtual chromoendoscopy in the upper and 
lower gastrointestinal (GI) tract no data are available for this method in the small bowel (4, 7-9). 
Here, we assessed the application possibilities and the value of FICE in different small bowel 
pathologies. 
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Case series: 
17 patients (10 female, 7 male; mean age 40 years, range 4-78) underwent double balloon 
enteroscopy (DBE) assisted virtual chromoendoscopy using FICE (Fuji EN-450 T5/20, (EPX-4400 
processor, Fuji Saitama, Japan) (4). All patients or respectively their legal representatives provided 
informed consent before endoscopy. The study was conducted according to the guidelines of 
Helsinki and approved by the ethics committee of our institution. Conscious sedation was 
performed using a combination of intravenous midazolam and propofol.  
Similar to the NBI technology of Olympus endoscopes, the digital processing system of FICE is 
able to switch over between an ordinary image and a virtual image immediately, at any time of the 
procedure, by a simple push of a button on the handle of the endoscope (4,7). The wavelengths of 
the various types of FICE were chosen based on previously published data (4). These settings can 
be also used to evaluate the esophagus, stomach and colon (7). The  chosen sets were  as follows: 
set A [or 1]: red (R) 520 nm, green (G) 450 nm and blue (B) 400 nm; set B [o2 2] R 500 nm, G 445 
nm, B 415 nm,; set C [or 3] R 500 nm, G 470 nm, B 420 nm; set D [or 4], R 500 nm, G 480 nm, 
and B 420 nm; set E [or 5] R 580 nm, G 520 nm, B 460 nm; and set F [or 6] R 550 nm, G 500 nm, 
B 470 nm (4). We simplified the letter (or number) classification by focusing on the predominant 
virtual chromoendoscopy color obtained for four sets: for set A [1] the predominant color is red, 
for set D [4] the predominant color is blue, for set E [5] the predominant color is orange and for set 
F [6] the predominant color is green. Figure 1 exemplifies this classification. 
Image Evaluation 
The targeted lesion was observed with standard white light (WL) settings and with FICE. First, two 
index pictures were obtained using WL. Then at least 2-4 pictures of the same lesion were 
sequentially obtained using the aforementioned FICE-settings. A total of 574 images were 
obtained. The following pathologies were evaluated (images are indicated in parenthesis): 
angiodysplasias n=4 (144); Crohn’s disease n=3 (78); NSAIDs enteropathy n=1 (38); 
malabsorption syndromes: celiac disease n=2 (76); primary small bowel lymphangiectasia n=1 
(24), Whipple’s disease n=1 (36); polyposis n=5: familial adenomatous polyp syndrome (FAP) n=2 
(58), Peutz-Jeghers n=1 (60), B-cell lymphoma n=1 (32), nodular lymphoid hyperplasia (NLH) 
n=1 (30). 
Endoscopic images were stored electronically in *.tiff format (300 dpi) and randomly allocated to 
two blinded readers (KM, LCF). No video recordings were stored routinely or evaluated for this 
study.  
Findings: 
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All four FICE spectral modes allowed the visualization and characterization of angiodysplasias 
(Table 1). However, only the blue mode (R 500 nm, G 480 nm, B 420 nm) permitted an improved 
characterization of angiodysplasias (Figures 1 A and B). We were able to define various types of 
angiodysplasias. Whereas the classic simple-shaped angiodysplasias were found most commonly, 
there were other small bowel angiodysplasias, too, which merely involved a few villi and appeared 
as a tiny conglomerate of microvessels. However, FICE did not improve the further sub-
classification of these vessels. In contrast, erosions had a heterogeneous appearance and acquired a 
white color upon switching to FICE (Figure 2). However, a true differentiation of angiodysplasias 
and erosions could not be proven because, for obvious reasons, we did not have a histological gold 
standard. Small bowel vessels could also be well defined at hepaticojejunostomy using white light 
and FICE.  
The detection or delineation of ulcers and erosions due to Crohn´s disease was not improved by 
FICE. WL was sufficient to locate and define these lesions.  
FAP polyps were flat, slightly raised, with irregular borders (Figure 3 A and B). The polyp surface 
had a cerebroid pit pattern. FICE clearly accentuated the surface contrast, thus enhancing the 
margin evaluation of FAP polyps.  In patients with FAP, FICE aided in the detection of additional 
polyps (Figures 4 A and B). The whitish surface of these polyps seen during WL endoscopy was 
markedly enhanced using any FICE setting. In one patient some of the polyps were flat and only 
visible with FICE (biopsy confirmed adenomas).  
Polyps associated with PJS were sessile or pedunculated, with a regular mucosal surface, and a 
serrated, thickened villous pattern (Figures 5 A-C). The use of FICE did not improve either the 
characterization or the additional detection of any PJS polyps as compared to standard WL.  
The patient with NLH had hundreds of small bowel pseudopolyps (Figure 6 A and B). These 
pseudopolyps resembled small hamartomatous polyps of PJS. However, the mucosal surface was 
smoother, non-distorted, with a regular pit pattern and similar in hue to the adjacent tissue, clearly 
different than the adenomatous polyps seen in FAP. 
Celiac disease 
The endoscopic findings in celiac disease included serrated folds, villous atrophy and mosaicism of 
the mucosa. No erosions or ulcers were found using either white light or FICE.  In the presence of 
mucosal atrophy the submucosal capillary network became more visible. However, FICE did not 
improve the detection of any mucosal characteristic in CD. The classic endoscopic features of CD 
were seen similarly using WL or FICE. However, due to its color contrast capabilities and the 
addition of endoscopic magnification, the characteristics of small bowel villi can be studied nicely 
using FICE (Figures 7 A-C).  
 - 57 - 
The small bowel mucosa of the patient with Whipple’s disease was edematous, with slightly 
engorged villi and with multiple white ring-like structures within the mucosa. FICE enhanced the 
white color of these rings, but it did not lead to the discovery of more such structures or additional 
lesions or mucosal characteristics not seen on white light endoscopy.  
In the patient with primary intestinal lymphangiectasia, the mucosal changes could be better 
appreciated using FICE but did not reveal any additional findings when compared with standard 
white light endoscopy (Figures 8A and B). In the patient with B-cell lymphoma the jejunal mucosa 
was normal with patchy areas of edema, which was more pronounced in proximity to several 
submucosal tumors. Here the villi were engorged and filled with whitish material. 
The inter- and intraobserver variabilities for the classification of small bowel polyps were assessed 
for each of the polyps (adenomatous versus non-adenomatous). There was excellent intraobserver 
and interobserver agreement for both white light and FICE (white light [= 0.94], FICE [= 0.96] 
and excellent interobserver agreement (white light [= 0.91], FICE [= 0.96]). 
 
Table 1: Utility of FICE for the evaluation of various small bowel pathologies.  
 
Condition FICE 
worse                     same                       improved 
Angiodysplasias                                                                        + 
Adenomatous polyp                                                                        + 
Peutz-Jeghers polyp                                    + 
Celiac disease                                    + 
Erosion                                    + 
Villous pattern of the mucosa                                    +* 
Crohn´s disease                                    + 
Whipple´s disease                                    + 
Primary intestinal lymphangietcasia                                    +** 
 
FICE= Fujinon intelligent color enhancement. The evaluation of whether FICE had any influence on the qualitative 
evaluation of the lesion as compared to white light endoscopy and was divided into three groups: worse, same or 
improved. ´Worse´ was defined as poor visualization of targeted lesion. ´same´ was defined as no change in visual 
characterisation and ´improved´ was defined as the ability to better characterize a lesion. Better characterisation could be 
achieved by either a better definition or delineation (i.e. demarcation) of the targeted lesion.  
* FICE allowed for the visualization of the tiny intravillous capillaries and enhances the submucosal capillary network. 
** The villous lymphatics were more visible with FICE. 
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Figure 1 A    Figure 1 B   Figure 2 
Figure 1 A and B: Visualization of angiodysplasias in using FICE. Panel A shows standard white light endoscopy 
of an angiodyplasia. With the blue mode (B) the angioectasia can be clearly demarcated from the surrounding mucosa 
and appears as an homogenous spot within the mucosa.  The actual theoretical advantage of FICE is that due to the 
vast amount of possible “wavelength mixes” that can be obtained, it is possible to evaluate the mucosa with various 
virtual “dyes”. In contrast, NBI from Olympus has only one set of filters, which currently cannot be easily manipulated 
to create more colors. However, we are not sure of whether having more options result in a better characterize of the 
mucosa or mucosal lesions. In essence, the major aspects that need to be considered when using any virtual methods is: 
a) capability to enhance the visualization of the mucosal surface and hence, improve pit pattern characterization, and b 
augment the visibility of the submucosal capillary network. 
Figure 2: Jejunal erosion. With FICE the erosion is clearly seen as a white filling defect of the mucosa. The other 
spotty mucosal findings seen on the right side represent detritus and small bowel fluids.  
 
 
Figure 3 A       Figure 3 B 
Figure 3: Adenomatous polyps associated with FAP. Panel A demonstrates an adenomatous FAP polyp of the proximal 
jejunum. Note the white color of the polyp as well as its clear demarcation from normal mucosa using FICE (B). The pit 
pattern of adenomatous polyps resembles that of colon polyps. However, neither previous studies using FICE in the colon 
nor we could define whether FICE is useful for differentiation of low from high grade dysplasia. Thus, the quest continues 
to evaluate whether any of the virtual or standard chromoendoscopy techniques can replace histology.   
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Figure 4 A    Figure 4 B 
Figure 4 : Adenomatous polyps associated with FAP. Panel A shows multiple small bowel polyps using standard white 
light endoscopy. With FICE it was possible to better delineate these polyps and due to the contrast enhancement it is 
possible to detect more lesions (panel B).  However, despite having increased the visualization of diminutive adenomatous 
polyps in FAP, FICE did not result in new diagnosis or changes in therapy. In addition it is possible to observe that white 
reflections tend to increase during the FICE mode, potentially interfering with the image. 
 
 
Figure 5 A    Figure 5 B   Figure 5 C 
Visualization and characterization of Peutz-Jeghers hamartomatous polyps using different FICE-settings.  
(A) Standard white light; (B) blue; (C) green. Although FICE did not improve the mucosal and villous evaluability of PJS 
polyps, the submucosal capillary pattern was enhanced. One might be confused by the fact that the predominant color for 
setting D is blue, when setting E (orange) and setting F (green) have higher components of blue. This effect might be 
related to the “mixture” resulting from the individual wavelengths which in turn leads to a predominant color. 
Interestingly, in NBI (Olympus) the predominant color is dark brown-grey, despite having high components of blue. If the 
bandwidths would be further manipulated, it would be possible observe different predominant colors in Olympus NBI as 
well. 
 
 
Figure 6 A    Figure 6 B 
 
Figure 6. Nodular lymphoid hyperplasia (NLH). White light (A) and FICE (B) were equivalent for the definition of the 
mucosal characteristics and delineation of the pseudopolyps in NLH. 
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Figure 7 A     Figure 7 B   Figure 7 C 
Figure 7: Jejunal villous architecture using white light (A) and FICE. Due to its color contrast capabilities and the 
addition of endoscopic magnification, the characteristics of small bowel villi can be studied nicely using FICE. In 
addition to allowing for the inspection of the villous structure, FICE permits the view of the intravillous capillary 
system (B). However, with the exception of the duodenal bulb, FICE did not allow us to differentiate the various parts 
(i.e. upper, middle or lower) of the normal small bowel mucosa. It is possible that using magnification endoscopy or 
the immersion technique that a better characterization of the villi can be achieved, and thus differentiate whether the 
mucosa is jejunum or ileum. The classic endoscopic features of CD were seen similarly using WL or FICE. However, 
due to its color contrast capabilities and the addition of endoscopic magnification, the characteristics of small bowel 
villi can be studied nicely using FICE (Figures 7 A-C).  
 
 
 
Figure 8 A      Figure 8 B 
Figure 8. Primary intestinal lymphangiectasia. White light endoscopy revealed engorged mucosal villi and 
lymphangiectasias (A). This could be better appreciated using FICE (B).  
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Discussion:  
In this study we found that FICE is a feasible virtual chromoendoscopy technique, which enhances 
the surface visualization of the small bowel mucosa. DBE with FICE technology was found to be a 
helpful method for the evaluation of small bowel polyps in patients with FAP, in the 
characterization of angiodysplasias and the definition of the submucosal capillary network.  
Data regarding the usefulness of FICE in identifying gastrointestinal vascular ectasias, colon 
polyps and intestinal metaplasia in the esophagus have been promising (4,7-9). In a pilot study 
FICE appeared to be as accurate as conventional chromoendoscopy in the detection of HGIN or 
early cancer and may therefore be appropriate for surveillance of Barrett’s esophagus (7). In 
another pilot study, Pohl et al. compared the feasibility of FICE, standard colonoscopy and 
conventional chromoendoscopy with indigo carmine for determination of colonic polyps and found 
that FICE not only identified morphological details that efficiently predict adenomatous histology, 
but that it was also superior to standard colonoscopy and equivalent to conventional 
chromoendoscopy (7). In our study FICE was useful for the characterization of small bowel polyps 
and pseudopolyps. Whereas FICE did not improve the definition of Peutz-Jeghers syndrome-
polyps, it was quite useful for defining adenomatous polyps associated with FAP and 
differentiating them from non-neoplastic polyps. FICE was useful to better delineate the margin of 
adenomatous polyps from healthy surrounding mucosa and was of further assistance for the 
detection of small jejunal polyps missed by conventional white light. In addition, margin 
evaluation may be useful when resecting polyps using snare or mucosectomy technique or ablating 
them with argon plasma. Thus, margin evaluation may permit a better delineation before resection 
and may allow confirmation of complete eradication.  
In a previous study using dye-based (indigo carmine) DBE-assisted chromoendoscopy, we showed 
that standard chromoendoscopy was useful for the characterization and detection of small bowel 
polyps in patients with FAP (10). Given the easier handling of FICE, this method may prove more 
useful for the screening and surveillance of these patients. Recently, Ringold et al. described two 
cases in which high contrast imaging with FICE improved the visibility of normal mucosal vessels 
and aided in the detection of vascular ectasias that were not easily seen by routine endoscopy (11). 
In our study, which included a larger number of patients, we reached similar observations.  
In summary, this is the first report on the potential utility of DBE with FICE to evaluate a broad 
spectrum of small bowel diseases. So it sets the basis for further prospective studies evaluating the 
usefulness of FICE for the differentiation and characterization of specific small-bowel pathologies 
such as polyps and angioectasias.  
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Abstract:  
Routine endoscopic imaging of the small bowel is performed with videoendoscopic white light 
technology. However, currently there are many new methods that improve our visual acuity when 
evaluating the small bowel mucosa. These methods are collectively called “advanced endoscopic 
imaging”. These imaging methods include high-definition white light endoscopy, standard and 
dyeless or “virtual” chromoendoscopy, magnification endoscopy and confocal endomicroscopy. 
Regardless of the method used to image the small bowel the endosocopist needs to pay attention to 
detail and focus on three essential aspects:  a) the shape of the lesion, b) the superficial mucosal 
detail (i.e. “pit pattern”) and c) the submucosal vessel pattern. This review describes advances in 
the endoscopic imaging methods to study the small bowel. 
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Introduction: 
The main aim of lumenal endoscopic visualization of the luminal gastrointestinal tract is to detect 
mucosal pathologies by studying the composition and distibution of folds, studying the mucosal 
detail (i.e. apperance of the villi) and viewing of the submucosal vessel pattern (1-3). All 
endoscopic imaging techniques further increase our ability to describe, delineate and characterize 
abnormal structures and lesions in great detail (3-5). Standard white light endoscopes permit gross 
examination of the small bowel mucosa permitting the recognition of minor and major defects such 
as erosions, ulcers, lymphangiectasias or abnormal duodenal folds. The water immersion technique 
increases our ability to inspect the small bowel villi by magnifying the view as well as providing a 
soluble medium where the villi and other superficial structures appear bigger and “move” inside 
the water (6-8). This technique can be very helpful when investigating conditions associated with 
villous atrophy such as celiac disease and other malabsorption syndromes (6, 7). Magnification or 
zoom endoscopy further increases our ability to analyze the mucosal detail (9, 10). By applying 
dyes and magnifying the mucosa (magnification chromoendoscopy) further architectural detail of 
the mucosa can be elucidated (10, 11). New dyeless or virtual chromoendoscopy techniques such 
as narrow band imaging (NBI), i-scan and Fujinon intelligent color enhancement (FICE) have 
further enhanced our optical capabilities for the evaluation of enteric mucosal and submucosal 
lesions (5, 12-14). Endocytoscopy and confocal laser endomicroscopy are currently the most 
advanced endoscopic techniques (3, 15-18). When using confocal laser endoscopy the targeted 
structure is magnified in such a way that a virtual histology image (“in vivo histology”) is achieved 
(16-18). We believe that in the near future confocal endomicroscopy may further help characterize 
and diagnose diseases affecting the small bowel such as celiac disease, Crohn’s disease, infections, 
vasculitis, mesenteric ischemia and angiodysplasias, among others. Table 1 shows a list of diseases 
resulting in destruction of the mucosa and submucosa of the small bowel. This review describes 
advances in the endoscopic imaging methods to study the small bowel. 
 
Principles of endoscopic inspection: 
The basic concept behind endoscopic imaging is the visualization and characterization of the 
lesion’s shape and its mucosal and submucosal architecture (1, 2). All benign or malignant mucosal 
and submucosal lesions will “stand out” from its surroundings by virtue of various characteristics 
such as growth, excavation, protrusion, villous destruction, villous flattening and submucosal 
vessel architecture (2).  
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Mucosal analysis: 
In the small bowel the main “player” is the villus, of which there exist several billion (Figure 1 A 
and B). Each villus is a unique “unit” that has a layer or coat of various types of cells, which have 
different functions and degrees of maturation from base to tip. Inside the villi there is a fine 
venocapillary and lymphatic network that is responsible for homeostasis, bringing oxygen to the 
cells and transporting absorbed elements (Figure 2). During inflammatory, neoplastic, angiogenetic 
and infiltrative porcesses this minute vessels become deranged and this can be observed at varying 
degrees with existing endoscopic imaging methods. In addition, any mucosal or submucosal lesion 
will have a superficial epithelial “pattern” (e.g. “pit pattern”) and characteristics borders which 
result from absorbance, reflection and shadowing of light. The surface changes result commonly 
from processes that are inflammatory, infiltrative, angioproliferative, destructive or which lead to 
ncontrolled growth of neoplastic cells.  
 
Submucosal capillary analysis: 
Submucosal inspection (or submucosal surface analysis) is focused on visualizing the underlying 
vascular pattern of a given lesion (1-5). As angiogenesis is a major marker and promoter of 
malignancy, the endoscopically observed submucosal capillary network of a small bowel polyp can 
provide us with a clue regarding its neoplastic degree. The submucosal vascular pattern can be 
described based on the vascular pattern intensity and individual vessel characteristics (2-4). Thus, 
vessels are characterized endoscopically based on their amount, length, convolutions, elongations, 
tortuosity, looping and proliferative patterns (1,2).  
 
Mucosal vessel derrangement: 
In addition to angiogenesis as a result of neoplasia often there are malformations and proliferation 
of the arteriovenous system. These vascular lesions are commonly called arteriovascular 
malformations (AVMs) or angiodysplasias. However, the term angiodysplasia is controversial as it 
implies “neoplastic” changes. Some endoscopists prefer to use the term angioectasia. In addition, a 
clear distinction should be made of venous and arterial malformations. A classic excample of a 
“venous” malformation are small bowel varices or veins present in the blue-rubber bleb syndrome 
(Fig. 3).  
 
The concept of multimodal, advanced small bowel imaging: 
Advanced endoscopic image refers to the utilization of tools that enhance mucosal and submucosal 
visualization. In essence, the characteristics of the mucosal surface and subsurface are accentuated 
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or even made visible. Advanced endoscopic imaging comprises techniques such as high definition 
white light, standard white light with chromoendoscopy, virtual chromoendoscopy, magnification 
as well as endomicroscopy for the evaluation of the gastrointestinal mucosa (1-5). The concept of 
using more than one imaging method when performing endoscopy is currently called multimodal 
endoscopy (3). For example, using a combination of standard white light and chromoendoscopy is 
an example of bimodal endoscopy. When using three methods the terminology changes to 
advanced trimodal imaging and so forth (4, 6).  
 
White light endoscopy: 
The curennt standard to investigate the small bowel mucosa is white light or high-definition white 
light endoscopy. Indeed, most of the published literature on small bowel diseases has based their 
results on white light observations.  
 
Water immersion technique: 
The water immersion technique is a relatively simple adjunct to endoscopy (7, 8). The basic 
principle of the water immersion technique consists of viewing the mucosa under water (6-8). The 
endosocopist flushes water through the working channnel of the endoscope and inundates the field 
of view. The mucosal villi appear larger and can be very well characterized (Figure 1B). In 
essence, this method is a “magnifying” technique. In the presence of mucosal atrophy the villi 
appear blunted or may even dissapear (Figure 4). The immersion technique has been most widely 
studied by Cammarota et al from Rome (6, 7). In several studies he and his group were able to 
demonstrate a high specificity and sensitivity to diagnose celiac disease. In one such study 
evaluating patients with serologically and histologically proven celiac diasease the endoscopic 
appearance of the duodenum with air insufflation alone had a positive predictive value for the 
diagnosis of celiac disease of 84% and a specificity of 87% (6). Visualization of villi with the 
water immersion technique had a higher positive predictive value (99%) and specificity (99%) (7). 
In a study designed to monitor the celiac patient’s response to a gluten-free diet the immersion 
techniques was a sgood as biopsy to detect villous blunting (7). Their data supports the concept of 
an endoscopy-based approach that avoids the need for biopsy when monitoring the dietary 
adherence and/or response of patients with an initial diagnosis of celiac disease (8). A biopsy 
remains standard for the initial diagnosis of celiac disease but when evaluating these patients on 
follow-up (i.e. surveillance), a good immersion technique investigation of the small bowel mucosa 
may suffice to detect active disease (i.e. villous blunting and atrophy).  
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Dye-based-Chromoendoscopy: 
Chromoscopic endoscopy relies on the instillation of a dye (e.g. indigo carmine or methylene blue) 
to highlight the superficial details and improve visualization of the mucosa. The contrast 
enhancement of the mucosal surface often results in an improved detection of subtle lesions. The 
various dye agents used for chromoendoscopy are divided in a) absorptive agents (Lugol, 
methylene blue, toludine blue, cresyl violet), b) contrast agents (indigo carmine, acetic acid) and c) 
reactive staining agents (congo red, phenol red). Dye agents are mostly applied via standard 
spraying or plain biliary biliary catheters. 
Patients with celiac disease have a 28−fold increased risk of developing enteropathy−associated 
T−cell lymphoma compared with the general population. Hadithi et al from Amsterdam described 
the chromoendoscopic appearances of jejunal enteropathy−associated T−cell lymphoma, before 
and after indigo carmine spraying, in a patient who was undergoing a double−balloon endoscopy 
(19). Scalloping or loss of folds, a mosaic appearance of the jejunal mucosa, and round or 
circumferential ulcers (10±90mm along their longitudinal axis) were detected with standard video 
endoscopy, but the villi were easier to recognize after indigo carmine staining of scalloped jejunal 
folds 
In a case series of patients with familial adenomatous polyposis syndrome we assessed the 
usefulness of double-balloon enteroscopy (DBE) assisted chromoendoscopy for the detection and 
characterization of small bowel polyps (11). In this prospective evaluation of patients with clinical 
and genetically proven FAP who were enrolled in endoscopic surveillance program DBE-assisted 
chromoendoscopy was performed with indigo carmin. Small bowel polyps (including papillary 
adenoma) were detected in 7/9 (88%) (Figure 5). Jejunal polyps were detected in 6/9 (67%) 
patients. Chromoendoscopy aided in the detection of additional polyps in two patients. In one 
patient the polyps were flat and only visible with chromoendoscopy (biopsy confirmed adenomas). 
Thus, DBE-assisted chromoendoscopy was assistance for the delineation and detection of jejunal 
polyps (11). 
 
Dye-less chromoendoscopy (“virtual” chromoendoscopy): 
Dye-less chromoendoscopy is divided into optical chromoendoscopy including narrow band 
imaging (NBI; Olympus, Tokyo, Japan) and virtual chromoendoscopy including i-scan (Pentax, 
Tokyo, Japan) and Fujinon intelligent color enhancement (FICE; Fujinon, Tokyo, Japan). While 
NBI is based on optical filters within the light source of the endoscope which narrow the 
bandwidth of spectral transmittance, thereby enhancing the visualization of blood vessels, i-scan 
and FICE use digital postprocessing for computed spectral estimation for better tissue contrast (1-
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3, 5, 12). Because these methods do not use dye but rely on either color filters or computerized 
color changes of the image, they are called “virtual chromoendoscopy” or dye-less 
chromoendosocpy. FICE is also called CVC (computed virtual chromoendoscopy), OBI (optical 
band image) or spectral estimation technology (SET) (1-3, 5, 12). The activation of the filter is 
simply done by pushing a button on the handle of the scope (1-3. 5). Similar to the NBI 
technology, the digital processing system of FICE or i-scan is able to switch over between an 
ordinary image and a virtual image immediately, at any time of the procedure, by a simple push of 
a button on the handle of the endoscope (1-3, 5, 12). A practical difference between NBI and FICE 
or i-scan needs to emphasized. NBI was developed to study the submucosal vessel pattern whereas 
FICE and i-scan are more useful to evaluate the shape, contour and structure of the mucosal 
surface.  
In a small case series evaluating three follicular lymphomas Chowdhury et al described the 
enteroscopic characteritiscs of this tumor using FICE (13). On white light endoscopy multiple 
nodular lesions and elevated white patches, multiple polypoid lesions, and scattered white polypoid 
and nodular lesions in the duodenum and small intestine were seen. FICE demonstrated small, 
whitish nodules, with a coiled, elongated vascular pattern within the elevated lesions (13).  
In the largest study published to date we evaluated the potential usefulness of FICE for 
characterizing various small bowel disease. A total of 574 images from 17 with the various 
pathologies including angiodysplasias, Crohn’s disease, NSAIDs enteropathy, celiac disease, 
primary small bowel lymphangiectasia, Whipple’s disease, familial adenomatous polyp syndrome, 
Peutz-Jeghers, B-cell lymphoma and  nodular lymphoid hyperplasia were studied (12). We found 
that all four FICE spectral modes allowed the visualization and characterization of angiodysplasias. 
However, only the blue mode (R 500 nm, G 480 nm, B 420 nm) permitted an improved 
characterization of angiodysplasias. However, angiodysplasias can always be clearly visualized 
used plain white light (Figure 6). The detection or delineation of ulcers and erosions due to 
Crohn´s disease was not improved by FICE. WL was sufficient to locate and define these lesions. 
FAP polyps were flat, slightly raised, with irregular borders (Figure 7). The polyp surface had a 
cerebroid pit pattern. FICE clearly accentuated the surface contrast, thus enhancing the margin 
evaluation of FAP polyps. The whitish surface of these polyps seen during WL endoscopy was 
markedly enhanced using any FICE setting.  
We are not aware of any studies evaluating the usefulness i-scan for detection and characterization 
of small bowel pathology. Banerjee and Reddy from Hyderabad, India have briefly reported on the 
potential use of high-resolution NBI with magnification for the detection and characterization of 
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celaic disease (14). Using this approach the authors were able to clearly visualize areas of patchy 
defects in celiac disease. 
 
Magnification endoscopy: 
Magnification endoscopy uses videoendoscopes with the capability to image magnification in a 
variable continuous range (up to 150 x) by using a movable lens controlled by the endoscopist (9, 
10, 20) (Figure 1). In a study aimed at finding villous atrophy Lo et al used the combination of 
enhanced magnification endoscopy with 3% acetic acid instillation in patients with celiac disease 
and tropical sprue (9). Using this method the authors were able to describe four different mucosal 
pit patterns: I, normal; II, stubbed; III, ridged; and IV, foveolar. Three of the 4 patterns were 
strongly associated with the presence of villous atrophy (pattern I, 1/18 [5.5%]; II, 16/17 [94%]; 
III, 12/12 [100%]; and IV, 5/5 [100%]). EME was more sensitive than standard endoscopy for 
detecting villous atrophy, 100% versus 58% in celiac disease and 93% versus 20% in tropical 
sprue. Furthermore, EME identified patchy areas of partial villous atrophy in 16 patients (5 CD and 
11 TS) in whom standard endoscopy was normal (9). We have also studied the characteristics of 
Whipple’s disease and other malabsorptive states using magnification endoscopy (20) (Figure 8).  
 
Endocytoscopy: 
Endocytoscopy is a novel diagnostic technique allowing in vivo real-time visualization of mucosa 
under x 450 magnification (15, 16). Matysiak-Budnik et al studied sixteen patients with 
documented celiac disease and seven controls without celiac disease. Endocytoscopic images 
obtained from several fields were compared in a blinded fashion to standard histology. 
Endocytoscopy showed three different patterns of in vivo histology: (1) the presence of normal-
appearing, long, thin villi; (2) the presence of thick, shortened villi, reflecting partial villous 
atrophy; and (3) the total absence of villi and the presence of enlarged crypt orifices, reflecting 
total villous atrophy. Good concordance between endocytoscopy and standard histology was found 
in all 16 patients with celiac disease.This preliminary study shows that endocytoscopy allows in 
vivo, real-time, noninvasive visualization and characterization of villous architecture and may be a 
promising method for in vivo evaluation of duodenal mucosa in celiac disease (15). 
In another study evaluating the usefulness of endocytoscopy for the diagnosis of celaic disease 
Heiko Pohl et al prospectively studied 166 endocytoscopy recordings of forty patients with 
established (n =32) or suspected (n = 8) celiac disease (16). Of the166 duodenal biopsy sites, 23% 
were classified as Marsh III (moderate to severe), 10% as Marsh I (mild), and 67% as Marsh 0 
(normal). Using the 450x magnification, we found that identification of crypts was diagnostic for 
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celiac pathology. Four criteria were significant predictors of Marsh III pathology when adjusted by 
multivariate analysis: low number of villi per visual field (<3), confluence of villi, irregular 
epithelial lining, and inability to delineate loop capillaries. However, none was a good predictor of 
Marsh I pathology (16). 
 
Confocal laser endomicroscopy: 
Confocal laser endomicroscopy (CLE) was introduced in 2004 and has rapidly emerged as a 
promising imaging method to obtain real time in vivo histology during ongoing endoscopy. The 
magnification equates that of white light microscopy, with image increases up to 1000 times (17, 
18). The technique is based on tissue illumination with a blue laser light after the topical 
(acriflavin, tetracycline, cresyl violet) or systemic (fluorescein sodium) application of fluorescence 
agents. Multiple images are then recorded at different depths of the the mucosal layer. The 
resolution of CLE ranges from 0.7 to 1 µm and a depth of 7 µm. The field of view is around 600 
µm (17, 18). CLE can be performed in two ways: a) a probe with bundled fibers which is advanced 
through the working channel of the endoscope, which is called probe-based CLE (pCLE) 
(Cellvizio, Mauna Kea technologies, Paris, France) or a miniature confocal scanner microscope 
which integrated into the tip of the endoscope (endoscope CLE or eCLE (Pentax®, Ft. Wayne, NJ, 
USA) (3, 35). The probe-based method is the most feasible for deep enteroscopy as it permits the 
advancement of the probe through the enteroscope. Currently there is not enteroscope available 
with an integrated scanner microscope on its tip. Nevertheless, the endoscope-based probe can also 
be used to study the mucosal detail of the duodenum, upper jejunum and terminal ileum (Figure 9).  
In an elegant study evaluating patients with suspected celiac disease Rupert Leong et al from 
Australia found that confocal laser endomicroscopy equates histology in its diagnsotic accuracy. 
The accuracy of CEM in diagnosing CD was excellent (receiver operator characteristics area under 
the curve, 0.946; sensitivity, 94%, specificity, 92%) and correlated well with the Marsh grading 
(R-squared, 0.756) (18). 
 
Summary: 
High-definition white light endoscopy is the standard imaging method to visualize the small bowel. 
New imaging methods are being investigated and offer fascinating possibilities to improve the 
detection and characterization of small bowel diseases. Every endoscopist interested in small 
bowel imaging should master the concept of multimodal and advanced imaging.  
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   Figure 1A     Figure 1B  
 
Figures 1 A and B. White light photos of the normal small bowel. Figure A is a standard white light image, figure B 
shows the water immersion technique (the villi are observed under water). 
 
 
 
 
 
 
     
 
Figure 2      Figure 3 
 
Figure 2. Inside the villi there is a fine vascular network which can be clearly observed using confocal laser 
endomicroscopy imaging. 
 
Figure 3. Classic arteriovenous malformations should be clearly distinguished from varicosities of the small bowel. 
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Figures 4 A-C 
Figures 4 A-C. Celiac disease. A. Serrated folds. B. Blunting and flattening of the villi (“mosaic pattern”). C. Water 
immersion view of flattened villi. 
 
 
 
 Figure 5    Figure 6    Figure 7 
Figure 5. Small bowel adenomas in patients with familial adenomatous polyposis (FAP) syndrome appear as 
protruded, whitish mucosal lesions (chromoendoscopy with indigo carmin). 
Figure 6. Small bowel angiodysplasias. A. Appearance with high-definition white light imaging.  
Figure 7. FAP polyps are flat, slightly raised, with irregular borders and a white surface (FICE). 
 
 
    Figure 8    Figure 9 
Figure 8. Magnification endoscopic view of Whipple’s disease. Note the characteristic white rings appear inside of the 
mucosal villi. 
Figure 9. Confocal laser endocmicroscopy of a patient with Crohn’s disease. The photo could well represent a 
histologic image. 
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Table 1. Examples of various diseaseas resulting in small bowel mucosal and submucosal 
abnormalities 
 
Luminal or mucosal destruction 
Ulcerative, inflammatory and/or autoimmune diseases 
Crohn´s disease 
Ulcerative jejunitis 
Eosinophilic gastroenterititis 
Vasculitis: Churg-Strauss, polyarteritis nodosa 
Celiac disease 
Tropical sprue 
Giardia lamblia 
Strongyloides stecoralis 
 
Infiltrative or submucosal destruction 
Mastocytosis 
Whipple´s disease 
Neoplastic or proliferative (lymphoma, metastasis) 
Adenomas 
Peutz-Jeghers syndrome 
Cronkhite Canada syndrome 
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Introduction
Small-bowel endoscopy is now an essential tool for the investigation of patients with suspected 
small-bowel disorders. The current endoscopic methods to investigate the small-bowel lumen are: 
video capsule endoscopy (VCE) and device-assisted enteroscopy (DAE). DAE comprises single 
balloon, double balloon, and spiral enteroscopy. The interest in small-bowel diseases and methods 
to diagnose and treat them endoscopically continues to increase, as reflected by the contributions to 
this year’s Digestive Disease Week (7–10 May 2011; Chicago, Illinois, USA).  
Device-assisted enteroscopy: technical aspects and sedation 
Air insufflation is vital to allow us to investigate the small-bowel lumen and its mucosal detail. 
However, hyperinsufflation results in patient discomfort. In addition, as a result of looping and 
bowel dilation, the ability of the endoscopist to advance the enteroscope is limited, thus decreasing 
intubation depth. Carbon dioxide (CO2) is rapidly absorbed from the bowel lumen and prevents 
distension of the abdomen during the endoscopic procedure. Thus, CO2 appears to be an ideal 
substitute for air in DAE In a large retrospective study involving 178 patients, Landaeta et al. 
showed that CO2 insufflation improved the depth of enteroscopy and resulted in less abdominal 
distension and pain compared with standard air insufflation (1). The main limitation of the study 
was its retrospective design. Nonetheless, there are already data published in the literature showing 
the advantages of CO2 for complex endoscopic investigations. Thus, CO2 should be considered a 
standard insufflation method for DAE. 
Current spiral enteroscopy requires an overtube with a raised spiral at the distal end. Akerman et al. 
presented their initial experience using a “motorized” spiral enteroscope (2). The motor is in the 
handle and drives the spiral rotation using foot pedal control, which has variable speed and torque 
and is electronically limited. The spiral segment is 5.5 mm high, 45-Fr in size, and is positioned 
20–41 cm from the end of the endoscope. The authors were able to observe an average of 400 cm 
in the first 18 patients studied. Amazingly, the procedure lasted, on average, slightly less than half 
an hour. If this equipment is not too expensive and further studies confirm these findings, we 
believe that the motorized spiral scope can become the next hit in small-bowel endoscopy. 
Balloon-assisted enteroscopy (BAE) is an advanced endoscopic method that can be both strenuous 
for the patient and the team performing the procedure. The procedure can be performed using 
sedation or general anesthesia. Sedation with propofol should always be administered by trained 
medical staff. In some countries propofol is only administered by anesthesia personnel (monitored 
anesthesia care [MAC]), whereas in some European countries (e.g. Germany, Switzerland) nurse-
assisted propofol sedation is widely and safely practiced. In The USA and many other countries 
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(e.g. Argentina, Brazil, France) general anesthesia is used to perform double balloon endoscopy 
(DBE). The main argument for using general anesthesia is assumed patient safety, possible better 
procedure tolerance, improved endoscopist satisfaction, and lower risk of complications. 
Interestingly, this issue has not been widely studied. Stephen et al. retrospectively studied the 
safety and efficacy of DBE performed under moderate conscious sedation and MAC/general 
anesthesia in a cohort comprising more than 200 patients (3). Although the average depth of 
insertion for DBE was 458 cm for general anesthesia compared with 358 cm for moderate sedation 
(P = 0.0814), the rate of complications was similar for both groups. The procedure was terminated 
early in three patients under moderate sedation due to increased agitation, and two patients under 
general anesthesia experienced anesthesia-related complications. This study is an important first 
step in this field and should prompt the performance of a prospective, multicenter study evaluating 
this issue.  
Capsule endoscopy: technical aspects 
The technical capabilities of VCE continue to increase and include increased capture time due to 
longer-lasting battery power, smaller size, improved photographic detail, and increased number of 
images shot. Standard capsule endoscopes capture two images/second (2/s). The SB2/4 capsule 
(Given Imaging, Yoqneam, Israel) is capable of capturing four images/second. In a clever study, 
Delvaux et al. evaluated whether 4/s resulted in a diagnostic increment compared with 2/s in a 
study involving 100 patients (4). The investigators were able to reach a diagnosis in 70 patients 
from the 4/s group, 69 from the 2/s group, 61 patients from the 4QV (4/s QuickView; Given 
Imaging), and 57 patients from the 4+2/s recordings, respectively. In 62 patients with multiple 
lesions, the number of lesions was significantly higher on the 4/s and 4QV recordings compared 
with the 2/s and 4+2/s recordings (P < 0.01). In summary, a higher frame rate at 4/s does not 
significantly increase the diagnostic yield of the small-bowel capsule, compared with the usual 2/s 
capsule. However, the 4/s capsule seemed to detect more individual lesions, during both normal 
and QuickView readings.  
Gastrointestinal bleeding 
Although the guaiac and fecal immunochemical tests (FIT) were mainly designed to screen for 
colorectal tumors, it is not known whether or not small-bowel lesions can also lead to a positive 
test. Levi et al. investigated whether gastroduodenal or small-bowel lesions found through VCE 
examination could result in positive FIT in 56 consecutive patients undergoing VCE for obscure 
occult gastrointestinal bleeding (OGIB) (5). Of the 26 patients (46.4%) with small-bowel lesions 
classified as a probable or suspected cause of bleeding, 12 patients (46.1%) had a positive FIT. In 
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contrast, only two out of 30 patients (6.6%) with normal small bowel had a positive FIT 
(P = 0.008). The sensitivity, specificity, and positive predictive value of FIT for small-bowel 
lesions classified as a probable or suspected source of bleeding were 46.2%, 93.3%, and 85.7%, 
respectively. Interestingly, none of the seven patients with gastroduodenal lesions classified as a 
probable or suspected source of bleeding had a positive FIT. These preliminary data suggests that 
the specificity of FIT for small-bowel lesions classified as a probable or suspected source of 
bleeding is acceptable. It seems reasonable to perform a small-bowel endoscopy in patients with 
negative colonoscopy with occult blood in stool. Of further interest, even in patients with upper 
gastrointestinal pathology findings that might explain the OGIB, a small-bowel endoscopy should 
still be considered (Figs. 1 and 2).  
Several studies have shown that BAE is useful for patients with OGIB. Safatle-Ribeiro et al. from 
São Paulo, Brazil, went a step further and classified the patients with OGIB into four groups: 
current overt (within 1 month after the last episode of overt bleeding), previous overt (more than 
1 month after the last episode of overt bleeding), current occult (anemia with positive fecal occult 
blood test within 1 month after the last episode of bleeding), and previous occult (chronic anemia) 
(6). In their prospective study comprising 130 patients, the authors identified a small-bowel 
bleeding etiology in 65.4% of patients. There was an association between the OGIB classification 
and the presence of the lesions in the small bowel: current overt (positive findings in 43.5%), 
previous occult (12.9%), current OGIB (overt or occult, 62.4%), and previous OGIB (overt or 
occult, 37.6%). In summary, we agree with the author’s recommendation to use BAE as an initial 
test in patients with current overt and occult gastrointestinal bleeding, reserving VCE for patients 
with previous overt and occult gastrointestinal bleeding. 
Crohn’s disease 
The diagnosis of Crohn’s disease, especially in cases of isolated small-bowel involvement, remains 
challenging (Figs. 3 and 4). Despite its known limitations small-bowel follow-through (SBFT) 
remains a standard test for detecting small-bowel Crohn’s disease. In a prospective, blinded, 
multicenter study, Ian Gralnek et al. determined the incremental diagnostic yield of VCE and 
compared this with that for ileocolonoscopy and SBFT in the diagnosis of small-bowel 
involvement in 50 patients with “suspected Crohn’s disease” (7). Interestingly, the incremental 
diagnostic yield of VCE (28.6%) compared with SBFT (18.4%) was not statistically significant. 
However, the combination of VCE and ileocolonoscopy (35.0%) had a trend toward higher 
diagnostic yield for detecting pathology in patients with suspected small-bowel Crohn’s disease 
compared with SBFT plus ileocolonoscopy (28.6%). Based on its enhanced ability to show the 
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mucosal detail we would have anticipated a clear-cut advantage of VCE over SBFT. These results 
underscore the need for using multiple imaging tests to diagnose Crohn’s disease.  
Nevertheless, the use of multiple tests is not always convenient, neither for the patient nor the 
physician. Thus, the order and timing of imaging tests for the diagnosis of suspected Crohn’s 
disease needs to be re-evaluated. In another prospective, multicenter, blinded cohort study, 
Leighton et al. evaluated whether VCE prior to ileocolonoscopy and SBFT impacts disease 
management in 74 patients with suspected Crohn’s disease (8). The physicians reported that VCE 
altered disease management in 24/74 patients (32%), ileocolonoscopy altered disease management 
in 17/73 patients (23%), and SBFT altered disease management in 10/70 patients (14%). This study 
supports the concept of a “step-wise, top-down” diagnostic approach for the diagnosis of suspected 
Crohn’s disease, which may revolutionize the way we approach diagnostics in Crohn’s disease. 
The diagnostic superiority of VCE compared with radiological tests was further confirmed in a 
large retrospective experience from the same group at the Mayo Clinic (Scottsdale, USA) (9). In a 
study comprising 114 patients, Boroff et al. found that VCE had a higher diagnostic yield and 
resulted in management change in a greater proportion of patients with established Crohn’s disease 
compared with patients with suspected Crohn’s disease. The authors also found that abnormal 
radiology testing did not correlate with abnormal VCE. However, because there was no clear “gold 
standard” to define small-bowel Crohn’s disease we do not know whether VCE missed these 
radiological lesions or whether these were true radiological false positives. Despite all these 
exciting data we need to remember that there are still no standardized and clearly validated criteria 
for capsule endoscopy in Crohn’s disease that are specific and sensitive for its diagnosis. Thus, we 
need studies evaluating these imaging methods using an accepted Crohn´s disease “gold standard”. 
Celiac disease and other malabsorptive states 
Despite the great improvement in serological testing, diagnosing celiac disease still requires 
duodenal biopsy coupled with a positive response to a gluten-free diet (Figs. 5–7). Nevertheless, 
the histological pattern of celiac disease is often patchy, with the risk of missed diagnoses. To 
evaluate the patchiness of the histological lesions along the small bowel, Di Nardo et al. performed 
push enteroscopy instead of conventional upper gastrointestinal endoscopy in 20 consecutive 
pediatric patients with suspected celiac disease (positive anti-transglutaminase and anti-endomysial 
antibodies) (10). Standard biopsies were taken from five different sites: bulb, second duodenum, 
fourth duodenum, proximal jejunum, and distal jejunum. A homogeneous pattern of histological 
damage was found in 10 patients (50%); five patients (25%) had a patchy pattern of lesions, 
whereas minor lesion variability among different sites was shown in nine patients (45%). The 
second and fourth duodenum were involved in 18 patients (90%). In one patient who lacked lesions 
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in the bulb and duodenum, the diagnosis of celiac disease could only be confirmed by proximal 
jejunal biopsies. This study confirms that celiac disease presents in a patchy pattern. Although 
most patients have involvement of the duodenum, a small but significant percentage only have 
jejunal disease. Never rule out celiac disease based solely on normal duodenum histology. 
Patients with celiac disease who do not respond to a gluten-free diet should undergo small-bowel 
imaging studies to identify refractory celiac disease (RCD) or enteropathy-associated T-cell 
lymphoma (EATL). Even though VCE has been used in this setting it is still unclear whether 
specific VCE parameters are associated with these conditions. Van Weyenberg et al. from 
Amsterdam aimed to identify parameters that discriminate between RCD type I and type II, and to 
identify features associated with RCD type II or EATL (11). In a retrospective, blinded evaluation 
of VCE studies on 52 patients with suspected RCD, a multivariate analysis showed that none of the 
proposed endoscopic findings could reliably help to distinguish RCD type I from RCD type II. 
However, the presence of proximal focal erythema and absence of progression of the capsule to the 
distal intestine were independently associated with the presence of RCD type II or EATL. Whereas 
only one of the 29 patients (3.4%) with none of these two features died during follow-up, six of 
seven patients (85.7%) with both features died during follow-up. This study shows that the 
endoscopic appearance of RCD is wide and that it is almost impossible to distinguish RCD type I 
from II based on these features. However, proximal focal erythema and absence of progression of 
the capsule to the distal intestine were strongly associated with RCD II and EATL making VCE a 
possible risk-stratification tool to predict survival in these patients. 
Common variable immunodeficiency disorder (CVID) is one of the most common 
immunodeficiency states in adults. Patients with CVID are prone to intestinal and extra-intestinal 
infections and malignancy, especially lymphomas. Few case reports and series have reported on 
the endoscopic findings of this disease. The most common finding reported in CVID is nodular 
lymphoid hyperplasia (NLH). Moneghini et al. studied the endoscopic findings in six patients with 
this immunoglobulin deficiency (median age 42 years) using VCE (12). The lesions described 
included normal mucosa, villous blunting, celiac-like atrophy, ileal mucosal erythema, aphthous 
ulcers, and NLH. Two patients had diffuse B-cell lymphoma of the small bowel. An important 
finding of this study was that the lesions were present in only part of the small bowel in most 
patients. Of note, the small-bowel ulcers were reminiscent of Crohn’s disease (see Figs. 3 and 4). 
Remember this clinical pearl: always think of CVID in patients with chronic diarrhea. 
The role of enteroscopy in the evaluation of malabsorptive disorders has not been widely studied. 
In a single-center, retrospective study, Ohmiya et al. studied 25 consecutive patients with protein-
losing enteropathy using VCE, DBE, and fluoroscopic enteroclysis (13). The diagnostic yield of 
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DBE was higher (100%) than that of fluoroscopic enteroclysis (60%) in 15 patients who underwent 
both tests, but not significantly different from VCE in 17 patients (DBE 82% vs. VCE 77%). The 
following diagnoses were made: intestinal lymphangiectasia, chronic nonspecific multiple ulcers of 
the small intestine unrelated to nonsteroidal anti-inflammatory drugs, intestinal amyloidosis, small-
bowel tumors, extragastrointestinal diseases, strongyloidiasis, Crohn’s disease, and small-bowel 
ulcers due to polyarteritis nodosa. It remains to be clarified how VCE had such a high diagnostic 
yield when tissue for diagnosis cannot be obtained using this method. This study shows that 
protein-losing enteropathy can be caused by a large number of pathologies and emphasizes the 
need for multiple imaging tests. 
Small-bowel polyps and tumors 
Until now there have only been three large studies published on the role of DBE for the diagnosis 
and treatment of small-bowel tumors. Dinesen et al. from Sydney, Australia, prospectively 
assessed the diagnostic and therapeutic impact of DBE in patients with suspected or documented 
small-bowel neoplasia seen on VCE or computed tomography (CT) scan (14). Over a 6-year 
period, a total of 580 DBE procedures were carried out. A total of 48 patients were found to have 
neoplastic disease/masses. A total of 35 tumors were detected prior to DBE (33 by VCE and two 
by CT), nine were suspected at VCE but only found at DBE, and two cases were missed by VCE 
altogether. The final pathology was: nine small submucosal lesions with normal biopsy (normal 
histology), four adenomas, three lymphomas, three lymphangitic cysts, two adenocarcinomas, one 
Meckels diverticulum, one hamartoma, one lymphoid hyperplasia, one lipoma, and one metastatic 
melanoma. Whereas four tumors could be managed endoscopically and three were resected 
surgically, 18 patients were followed clinically and three underwent chemotherapy for lymphoma. 
This large study supports the utility of DBE for the management of small-bowel tumors.  
In another study on the topic of small-bowel tumors, Mann et al. searched for a primary tumor site 
in 39 patients with metastatic neuroendocrine tumors (NET) using VCE, DBE, endoscopic 
ultrasound (EUS), octreotide scan, and positron emission tomography (PET)–CT (15). Although 
none of the imaging tests alone found all of the tumors, a primary NET was identified in 30 
patients (77%) with various combinations of VCE, DBE, and EUS. Of interest, octreotide scan, 
which is typically considered the gold standard, had a sensitivity of only 59%. PET–CT scans were 
done on four patients and all were negative. This interesting study shows the necessity of utilizing 
various imaging methods for the diagnosis of primary NET in patients with metastatic disease. We 
look forward to seeing the full publication as we hope the authors will propose an algorithm for the 
stepwise use of the various tests. 
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Therapeutic small-bowel enteroscopy 
The advent of DAE has not only revolutionized the way we observe the small bowel but has also 
brought means to treat various small-bowel pathologies. In a large retrospective, three-center 
study, Jovanovic et al. analyzed the results of therapeutic small-bowel endoscopy in a large cohort 
of patients (16). A total of 534 patients underwent 614 DBE over a 5-year period. A therapeutic 
small-bowel endoscopy was performed in 121 patients (22%). Therapeutic procedures included 
argon-plasma-coagulation (APC) of vascular lesions (n = 73), polypectomy (n = 49; the range of 
polyps resected in each patient with Peutz–Jeghers syndrome [PJS] and familial adenomatous 
polyposis was 1–15, mean 4), mucosectomy (n = 5), stricture dilation (n = 7), foreign body 
extraction (n = 7; capsule endoscopy, needles, coins), injection of fibrin glue (n = 10), and clip 
placement (n = 5). There were a total of five complications (0.9%; paralytic ileus [n = 2], 
pancreatitis [n = 1], bleeding [n = 1]). No perforation or death occurred. This study is of interest as 
it shows that therapeutic small-bowel endoscopy is performed in a fifth of patients undergoing 
BAE. Thus, endoscopists who perform DBE should be trained in and prepared to provide 
therapeutic interventions for small-bowel disorders, including APC, injection, hemoclipping, 
polypectomy, mucosectomy, and foreign body extraction. Therapeutic small-bowel endoscopy, 
albeit associated with complications in about 1% of cases, can be considered a relatively safe 
procedure. 
Kopacova et al. from Prague presented one of the largest experiences worldwide of diagnostic and 
therapeutic DBE for PJS (17). A total of 27 DBEs were performed in 13 patients with PJS, in 
whom a total of 344 polyps (1–46 hamartomas, mean of 13 per session) were removed. Although 
the complication rate per polypectomy was only 0.9%, the per-patient complication was 15% – one 
bleeding episode (treated endoscopically) and three perforations (two acute, one late). In our view, 
enteroscopy is the main route for the removal of polyps in PJS. We always have the surgeon on 
stand-by when treating these patients. If a perforation is sealed endoscopically or with immediate 
surgery the patient outcome is good.  
And finally, we want to discuss a new therapeutic indication for DAE: placement of a direct 
percutaneous endoscopic jejunostomy (DPEJ). Aktas et al. from the Erasmus University Medical 
Center, Rotterdam, prospectively assessed the efficacy and safety of DPEJ using the single-balloon 
enteroscopy technique in consecutive patients referred to this academic tertiary center for jejunal 
tube feeding (18). During an 8-month period, 12 DPEJ procedures were performed in 11 patients. 
All procedures were performed under conscious sedation using midazolam and fentanyl. DPEJ was 
successful in 11 of the 12 procedures (92%). In one patient DPEJ was not possible because of 
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failure to transilluminate a satisfactory location for insertion. This study shows that single balloon 
endoscopy-assisted percutaneous jejunal feeding tube placement is a useful and successful 
approach for patients requiring long term jejunal access.  
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  Figure 1  Figure 2  Figure 3 
 
  Figure 4 Figure 5 Figure 6 
 
Figure 7 
Fig. 1 Multiple angioectasias in a patient with Osler–Weber–Rendu (double balloon 
enteroscopy). 
Fig. 2 Bleeding angioectasia in a patient with overt gastrointestinal bleeding (capsule 
endoscopy). It might be better to first perform device-assisted enteroscopy in such a patient as this 
offers the ability to perform endoscopic hemostasis. 
Fig. 3 Aphthous ulcer in Crohn’s disease (capsule endoscopy). 
Fig. 4 Multiple ulcers and a stenosis in a patient with Crohn’s disease. The stenosis was dilated 
with a through-the-scope over-the-wire balloon. 
Fig. 5 Typical mosaic pattern of atrophic mucosa. In this case this is celiac disease (capsule 
endoscopy). 
Fig. 6 Serrated appearance of the mucosa in the presence of significant atrophy (double balloon 
enteroscopy, celiac disease). 
Fig. 7 Device-assisted enteroscopy allows for the retrieval of tissue for examination. Note the 
mucosal atrophy and the large number of intraepithelial lymphocytes in this patient with celiac 
disease. 
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XI. Chapter 10 Summary/Zusammenfassung 
In this thesis we aimed to investigate on the technique and clinical applications of double-balloon 
enteroscopy.  
In the first study (chapter four) we evaluated the learning curve of DBE. We found that DBE is not 
only time consuming but also is a challenging procedure. We demonstrated that there was a 
significant improvement in DBE performance over time, including increased depth of insertion, 
decline in procedural time, “speed of insertion” and decreased used of fluoroscopy for both oral 
and anal DBE procedures. These parameters improved significantly after the initial 10 oral (15 
anal) cases. Knowledge of this technical data will be helpful for endoscopists planning to perform 
DBE, to plan the caseload in individual endoscopy units and for establishing baselines for DBE 
skill certification. Future studies using the therapeutic DBE and comparing the learning curve 
using various types of enteroscopy are worth conducting. In summary, it appears that a minimum 
of 10-15 procedures is required to acquire the skills necessary to perform DBE.  
In the second study (chapter five) we performed the first study investigating the utility of DBE in 
patients with malabsorption of small bowel origin. We found that DBE had a high diagnostic yield 
in a selected group of patients with malabsorption in whom previous extensive investigations had 
been negative, being useful to reach a new diagnosis in 33% and to confirm the diagnosis in two 
thirds of patients investigated. In addition DBE was useful to rule out complications of long-
standing celiac disease such as ulceratice jejunitis or EATL.This high yield does not mean that 
DBE should be used as a primary tool in patients with malabsorption. Our study rather 
demonstrates that malabsorptive diseases with primary small bowel mucosal involvement could be 
adequately evaluated with DBE. Our study confirms that reaching a diagnosis in patients with 
malabsorption of small bowel. 
In the third study (chapter six) we critically investigated the role of double balloon enteroscopy in 
patients with obscure gastrointestinal bleeding. We found that the frequency of lesions within reach 
of conventional upper and lower endoscopes definitely explaining the source of GI bleeding in 
patients referred for DBE was 24.3%. These lesions included peptic ulcers, colonic 
angiodysplasias, Cameron’s lesions and radiation proctitis. Our study demonstrated that a carefully 
endiscopical investigation of upper and lower GI-tract can avoid unnecessary DBE which result in 
patient inconvenience, possible complications allowing a better allocation of endoscopist, nurses 
and material resources in the endoscopy unit. Therefore, a repeat EGD and ileocolonoscopy should 
be considered before DBE. And these examinations should be performed thoroughly. Further 
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studies focusing on the clinical and laboratory factors that can predict the etiology of small bowel 
pathologies in the setting of OGIB are warranted. 
In the fourth study (chapter seven) we were the first group to investigate the feasibility of virtual 
chromoendoscopy techniques of the small bowel. We found that DBE with FICE technology is a 
helpful advanced endoscopic method for the evaluation and characterization of small bowel polyps 
and pseudopolyps in patients with familial adenomatous polyposis (FAP), in the characterization of 
angiodysplasias and the definition of the submucosal capillary network.  Whereas FICE did not 
improve the definition of Peutz-Jeghers syndrome-polyps, it was quite useful for defining flat 
adenomatous polyps associated with FAP and differentiating them from non-neoplastic polyps. 
FICE was useful to better delineate the margin of adenomatous polyps from healthy surrounding 
mucosa and was of further assistance for the detection of small jejunal polyps missed by 
conventional white light. In addition, margin evaluation may be useful when resecting polyps using 
snare or mucosectomy technique or ablating them with argon plasma. Thus, margin evaluation may 
permit a better delineation before resection and may allow confirmation of complete eradication. 
In the state-of-art review (chapter eight) we present and discuss on advanced endoscopic imaging 
possibilities for small bowel disorders. The standard imaging method to visualize the small bowel 
is the high-definition white light endoscopy. During the last years new imaging methods are being 
investigated, offering new possibilities to improve the endoscopic detection and characterization of 
small bowel diseases. With these methods the mucosal surface and subsurface are accentuated or 
even made visible in a new concept called multimodal and advanced imaging. Advanced 
endoscopic imaging comprises techniques such as high definition white light, standard white light 
with chromoendoscopy, virtual chromoendoscopy, magnification as well as endomicroscopy for 
the evaluation of the gastrointestinal mucosa. The use of more than one imaging method when 
performing endoscopy is currently called multimodal endoscopy. Endocytoscopy and confocal 
laser endomicroscopy are currently the most advanced endoscopic techniques achieving a virtual 
histology image (“in vivo histology”). 
In the current review (chapter nine) we present the latest developments of DBE. Since its 
development in 2004 double-balloon-enteroscopy has quickly become the standard deep 
enteroscopy method for the investigation and treatment of small bowel disorders. Now, other uses 
for DBE include colonoscopy, ERCP, creation of jejunostomy and gastrostomy access in patients 
with bypassed stomach. Despite its advances balloon- and spiral enteroscopy methods are still time 
consuming, cumbersome and do not permit for a one-step total enteroscopy. Thus, further research 
into simplifying and improving these endoscopic methods is warranted and in progress.  
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Zusammenfassung 
 
Ziel dieser Dissertation ist die Untersuchung der technischen und klinischen Anwendung der 
Doppelballonenteroskopie. 
Im ersten Teil der Studie (Kapitel vier) erfolgte die Evaluation der Lernkurve der 
Doppelballonenteroskopie. Hier konstatierten wir, dass die Doppelballonenteroskopie nicht nur 
eine zeitaufwändige, sondern auch eine anspruchsvolle Untersuchung ist. Wir demonstrierten eine 
signifikante Verbesserung der Untersuchungstechnik mit zunehmender Erfahrung, eine 
zunehmende Untersuchungstiefe, eine deutliche Verkürzung der Untersuchungszeit mit rascherem 
Vorschub des Endoskopes und eine verminderte Durchleuchtungszeit für die orale und anale 
Doppelballonenteroskopie. Diese Parameter verbesserten sich deutlich nach initialen 10 oralen 
beziehungsweise nach 15 analen Doppelballonenteroskopien. Kenntnisse dieser technischen Daten 
helfen dem Endoskopiker bei der Planung einzelnen Doppelballonenteroskopie, bei der Planung 
der Untersuchungsfülle einzelner Endoskopieeinheiten und bei der Etablierung von 
Mindeststandards für die Doppelballonenteroskopie. Weitere Studien mit Vergleich 
unterschiedlicher Enteroskope und der jeweiligen Lernkurve sollten in Zukunft durchgeführt 
werden. Zusammenfassend ist festzustellen, dass ein Minimum von 10-15 Untersuchungen 
notwendig ist um ausreichende Fähigkeiten zur Durchführung einer Doppelballonenteroskopie zu 
erlangen. 
Der zweite Teil der Untersuchung (Kapitel fünf) untersucht als erste Studie überhaupt die 
Sinnhaftigkeit der Doppelballonenteroskopie bei Patienten mit Malabsorption im Rahmen einer 
Dünndarmerkrankung. Die Doppelballonenteroskopie besitzt einen hohen Stellenwert bei Patienten 
mit Malabsorption, bei denen vorherige, umfangreiche Untersuchungen negativ ausgefallen waren. 
Bei 33 % der Pat. konnte eine Neudiagnose erfolgen, bei 2/3 der Patienten konnte die vorherige 
Verdachtsdiagnose bestätigt werden. Zusätzlich zeigte die Doppelballonenteroskopie einen Nutzen 
bei Diagnose von Komplikationen einer langjährigen Zöliakie, wie einer ulzerierenden Jejunitis 
oder einer EATL. Diese hohe diagnostische Ausbeute bedeutet natürlich nicht, dass die 
Doppelballonenteroskopie das diagnostische erste Mittel zur Abklärung einer Malabsorption ist. 
Unsere Studie demonstriert aber, dass eine malabsorptive Erkrankung mit Beteiligung der 
Dünndarmmukosa gut und ausreichend mit der Doppelballonenteroskopie untersucht werden kann. 
Der dritte Teil der Studie (Kapitel sechs) untersucht kritisch die Rolle der 
Doppelballonenteroskopie bei obskurer, gastrointestinaler Blutung. Bei den Patienten, die mit der 
Frage nach einer obskuren gastrointestinalen Blutung zur Doppelballonenteroskopie zugewiesen 
wurden, fanden wir eine Blutungsquelle bei 24,3 % der Patienten mittels konventioneller oberer 
oder unterer Endoskopie. Die gefundenen Läsionen umfassten dabei peptische Ulzera, 
 - 93 - 
Angiodysplasien des Colons, Cameron Läsionen und Strahlenproktitiden. Unsere Untersuchung 
demonstriert, dass durch die sorgfältige Untersuchung des oberen und unteren 
Gastrointestinaltraktes unnötige Doppelballonenteroskopien und andere invasive Verfahren 
vermieden werden können. Dies verhindert einen Discomfort des Patienten, vermeidet potentielle 
Komplikationen und ermöglicht einen besseren und gezielteren Einsatz der Ressourcen von 
Endoskopikern, Pflegepersonal und Material. Deshalb sollte vor Einsatz der 
Doppelballonenteroskopie eine erneute ÖGD und Ileokoloskopie erwägt werden. Diese 
Untersuchungen sollten sorgfältigst durchgeführt werden. Weitere Studien klinischer und 
laborchemischer Faktoren als Prädiktoren einer mittleren, gastrointestinalen Blutung sollten in 
Zukunft durchgeführt werden. 
Im vierten Studienteil (Kapitel sieben) berichten wir als erste Arbeitsgruppe überhaupt über die 
Durchführung der Technik der virtuellen Chromendoskopie des Dünndarms. Die 
Doppelballonenteroskopie mit FICE (engl. Fujinon image chromoenhancement) Technologie ist 
eine hilfreiche endoskopische Methode zur Evaluation und Charakterisierung von 
Dünndarmpolypen und Pseudopolypen bei Patienten mit familiärer adenomatöser Polyposis coli. 
Weiterhin ist sie hilfreich in der Charakterisierung von Angiodysplasien und des submukösen 
Kapillarnetzes. Obwohl FICE die Charakterisierung von Peutz-Jeghers Polypen nicht verbesserte, 
war es doch hilfreich für das Erkennen von flachen adenomatösen Polypen, die mit der FAP 
assoziiert sind und bei der Abgrenzung dieser von nicht neoplastischen Polypen. FICE zeigte sich 
außerordentlich hilfreich bei der Abgrenzung von adenomatösen Polypen zur normalen Mukosa 
und der Detektion von kleinen jejunalen Polypen, die in der normalen Weißlichtendoskopie nicht 
sichtbar waren. Die Abgrenzung zur normalen Mukosa scheint besonders sinnvoll vor Resektion 
eines Polypen in Schlingen- oder Mukosektomietechnik oder vor einer geplanten 
Argonplasmaablation.  
In Kapitel acht werden die modernen endoskopischen Darstellungsmöglichkeiten für 
Erkrankungen des Dünndarms erläutert. die Standardmethode ist weiterhin die 
Weißlichtendoskopie. Währen der letzten Jahre wurden mehrere Methoden vorgestellt, die neue 
Möglichkeiten zur Detektion und Charakterisierung von Dünndarmerkrankungen bieten. Mit 
diesen Methoden kann die Mukosa und Submukosa akzentuiert dargestellt werden. Neuere 
Darstellungstechniken wie die hochauflösende Weißlichtendoskopie, die 
Standardweisslichtendoskopie mit Chromendoskopie, die virtuelle Chromendoskopie, die 
Magnifikationsendoskopie stehen für die Untersuchung der gastrointestinalen Mukosa zur 
Verfügung.  Der Gebrauch mehrerer dieser Techniken bei der Endoskopie wird als multimodale 
Endoskopie bezeichnet. Endocytoskopie und die confokale Laserendomikroskopie sind aktuell die 
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fortschrittlichsten Technologien und ermöglichen ein virtuelles histologisches Bild („in vivo 
Histologie“). 
Im Kapitel neun werden die letzten Entwicklungen der Doppelballonenteroskopie präsentiert. Seit 
der Einführung der Doppelballoneteroskopie 2004 hat sie sich zur Standardmethode für die 
Untersuchung und Behandlung von Dünndarmerkrankungen entwickelt. Die 
Doppelballoneteroskopie wird heutzutage auch für die Durchführung schwieriger Coloskopien 
endoskopische retrograde Cholangiopankreatographien (ERCP), Platzierung von perkutanen 
endoskopischen Jejunsotomien und Gastrostomien benutzt. 
Trotz aller Fortschritte in der Ballon- und Spiralenteroskopie sind diese Techniken weiterhin 
zeitaufwendig, anspruchsvoll und erlauben normalerweise nicht die totale Dünndarmendoskopie in 
einem Schritt. In Zukunft werden weiterhin Anstrengungen zur Vereinfachung und Verbesserung 
dieser Methoden notwendig sein. 
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